We have audited the accompanying consolidated
balance sheets of Creatd, Inc. (the “Company”) as of December 31, 2022 and 2021, and the related statements of operations
and comprehensive income (loss), stockholders’ equity (deficit), and cash flows for each of the years in the two-year period ended
December 31, 2022, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements
present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its
operations and its cash flows for each of the years in the two-year period ended December 31, 2022, in conformity with accounting principles
generally accepted in the United States of America.
The accompanying financial statements have been
prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company had
a significant accumulated deficit, significant net loss and net cash used in operating activities that raise substantial doubt about its
ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 3. The financial statements
do not include any adjustments that might result from the outcome of this uncertainty.
These financial statements are the responsibility
of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our
audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are
required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and
regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the
standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged
to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding
of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s
internal control over financial reporting. Accordingly, we express no such opinion.
Our audits included performing procedures to assess
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
The critical audit matters communicated below
are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to
the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our
especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion
on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions
on the critical audit matters or on the accounts or disclosures to which they relate.
As discussed in Note 2 to the financial statements,
management conducts a goodwill impairment assessment on an annual basis and when events or changes in circumstances indicate that the
carrying value of a reporting unit exceeds its fair value. The fair value of a reporting unit is determined through the use of the income
approach using estimates of future cash flows attributable to the respective reporting units. As a result of the annual impairment assessment,
the Company recognized approximately $1.4 million of goodwill impairment related to its reporting units.
Additionally, as discussed in Note 2 to the financial
statements, management evaluates the recoverability of acquired finite-lived intangible assets for possible impairment whenever events
or circumstances indicate that the carrying amount of such assets may not be recoverable. Recoverability of these assets is measured by
a comparison of the carrying amounts to the future undiscounted cash flows the assets are expected to generate from their use and eventual
disposition. As a result of the intangible asset impairment assessment, the Company recognized approximately $1.9 million of impairment
related to finite-lived intangible assets.
We identified the impairment of Goodwill and finite-lived
intangible assets as a critical audit matter because of significant judgments required by management to estimate the fair value, including
forecasted cash flows, revenue growth rates and expectations for operating expenses. The Goodwill assessment also requires judgment related
to the discount rate utilized and other significant valuation assumptions. This required a high degree of auditor judgment and an increased
extent of effort when performing audit procedures to evaluate the reasonableness of management’s cash flow estimates and the selection
of cash flow multiples used in the income approach for valuing Goodwill.
Our audit procedures related to the forecasts
of management’s estimates of future cash flows, the selection of cash flow multiples for the Company’s reporting units, and
the evaluation of the discount rate for Goodwill assessments included the following, among others:
As discussed in Note 2 to the financial statements,
inventories are stated at the lower of cost (first-in, first-out basis) or net realizable value and are periodically evaluated to identify
obsolete or otherwise impaired products and are written off when management determines usage is not probable. The Company estimates the
balance of excess and obsolete inventory by analyzing inventory by age using last used and original purchase date and existing sales pipeline
for which the inventory could be used.
We identified the audit of inventory as a critical
audit matter for the following reasons based on different aspects of the audit of inventory.
Our audit procedures related to the testing the
existence and valuation of inventory included the following, among others:
The accompanying notes are an integral part of
these consolidated financial statements.
Creatd, Inc.
Consolidated Statements of Cash Flows
| |
For the Year Ended | | |
For the Year Ended | |
| |
December 31, 2022 | | |
December 31, 2021 | |
| |
| | |
| |
CASH FLOWS FROM OPERATING ACTIVITIES: | |
| | |
| |
Net loss | |
$ | (35,676,315 | ) | |
$ | (37,379,153 | ) |
Adjustments to reconcile net loss to net cash used in operating activities: | |
| | | |
| | |
Depreciation and amortization | |
| 586,109 | | |
| 397,440 | |
Impairment of investment | |
| 50,000 | | |
| 589,461 | |
Impairment of intangible assets | |
| 1,433,815 | | |
| 1,038,905 | |
Impairment of goodwill | |
| 2,043,011 | | |
| 688,127 | |
impairment of ROU | |
| 101,623 | | |
| - | |
Accretion of debt discount and issuance cost | |
| 4,668,039 | | |
| 3,612,669 | |
Share-based compensation | |
| 4,183,844 | | |
| 9,661,174 | |
Shares issued for in process research and development | |
| 40,994 | | |
| - | |
Bad debt expense | |
| 398,130 | | |
| 110,805 | |
(Gain) loss on extinguishment of debt | |
| 832,482 | | |
| (1,304,677 | ) |
Settlement of vendor liabilities | |
| 265,717 | | |
| (59,692 | ) |
Change in fair value of derivative liability | |
| (3,729 | ) | |
| 1,096,287 | |
Derivative Expense | |
| - | | |
| 100,502 | |
Loss on marketable securities | |
| 11,742 | | |
| - | |
Non cash lease expense | |
| 274,784 | | |
| 82,511 | |
Reserve for obsolete inventory | |
| 399,058 | | |
| - | |
Equity interest granted for other income | |
| - | | |
| (123,710 | ) |
Equity in net loss from unconsolidated investment | |
| - | | |
| 16,413 | |
Changes in operating assets and liabilities: | |
| | | |
| | |
Prepaid expenses | |
| 86,155 | | |
| (174,819 | ) |
Inventory | |
| (479,356 | ) | |
| (39,182 | ) |
Accounts receivable | |
| (755,907 | ) | |
| (80,407 | ) |
Deposits and other assets | |
| (78,280 | ) | |
| (527,115 | ) |
Deferred revenue | |
| 65,250 | | |
| 144,851 | |
Accounts payable and accrued expenses | |
| 4,773,551 | | |
| 1,714,902 | |
Operating lease liability | |
| (26,146 | ) | |
| (84,099 | ) |
Net Cash Used In Operating Activities | |
| (16,805,429 | ) | |
| (20,518,807 | ) |
| |
| | | |
| | |
CASH FLOWS FROM INVESTING ACTIVITIES: | |
| | | |
| | |
Cash paid for property and equipment | |
| (212,249 | ) | |
| (95,935 | ) |
Cash paid for minority investment in business | |
| - | | |
| (325,000 | ) |
Cash paid for equity method investment | |
| - | | |
| (510,000 | ) |
Cash paid for investments in marketable securities | |
| (48,878 | ) | |
| - | |
Sale of marketable securities | |
| 37,135 | | |
| - | |
Cash received from the Sale of non-controlling interest in OG Collection Inc. | |
| 750,000 | | |
| - | |
Cash consideration for acquisition | |
| (31,679 | ) | |
| (225,947 | ) |
Purchases of digital assets | |
| (410,369 | ) | |
| (11,241 | ) |
Sale of digital assets | |
| 289,246 | | |
| - | |
Net Cash Provided By (Used In) Investing Activities | |
| 373,206 | | |
| (1,168,123 | ) |
| |
| | | |
| | |
CASH FLOWS FROM FINANCING ACTIVITIES: | |
| | | |
| | |
Proceeds from the exercise of warrant | |
| 1,781,947 | | |
| 9,487,223 | |
Net proceeds from issuance of notes | |
| 2,219,219 | | |
| 747,937 | |
Repayment of notes | |
| (2,830,382 | ) | |
| (456,233 | ) |
Proceeds from issuance of convertible note | |
| 8,391,905 | | |
| 3,610,491 | |
Repayment of convertible notes | |
| (1,863,315 | ) | |
| (941,880 | ) |
Repayment of note payable - related party | |
| - | | |
| (538,574 | ) |
Proceeds from issuance of common stock and warrants | |
| 5,722,300 | | |
| 5,666,951 | |
Cash received for preferred series E and warrants | |
| - | | |
| 40,000 | |
Purchase of treasury stock | |
| (16,050 | ) | |
| - | |
Net Cash Provided By Financing Activities | |
| 13,405,624 | | |
| 17,615,915 | |
| |
| | | |
| | |
Effect of exchange rate changes on cash | |
| (61,911 | ) | |
| (41,038 | ) |
| |
| | | |
| | |
Net Change in Cash | |
| (3,088,510 | ) | |
| (4,112,053 | ) |
| |
| | | |
| | |
Cash - Beginning of period | |
| 3,794,734 | | |
| 7,906,787 | |
| |
| | | |
| | |
Cash - End of period | |
$ | 706,224 | | |
$ | 3,794,734 | |
| |
| | | |
| | |
SUPPLEMENTARY CASH FLOW INFORMATION: | |
| | | |
| | |
Cash Paid During the Year for: | |
| | | |
| | |
Income taxes | |
$ | - | | |
$ | - | |
Interest | |
$ | 650 | | |
$ | 60,073 | |
| |
| | | |
| | |
SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES: | |
| | | |
| | |
Settlement of vendor liabilities | |
$ | - | | |
$ | 168,667 | |
Beneficial conversion feature on convertible notes | |
$ | 2,008,227 | | |
$ | - | |
Warrants issued with debt | |
$ | 3,149,270 | | |
$ | 1,665,682 | |
Shares issued with debt | |
$ | 409,945 | | |
$ | - | |
Issuance of common stock for prepaid services | |
$ | 141,150 | | |
$ | 226,500 | |
Recognition of Right-of-use asset and corresponding operating lease liability | |
$ | 2,412,221 | | |
$ | - | |
Deferred offering costs | |
$ | - | | |
$ | 4,225 | |
Common stock and warrants issued upon conversion of notes payable | |
$ | 1,061,088 | | |
$ | 5,156,994 | |
Shares issued for acquisition | |
$ | - | | |
$ | 1,318,218 | |
Reduction of ROU asset related to re-measurement of lease liability | |
$ | - | | |
$ | 135,086 | |
Repayment of promissory notes from Australian R&D credits | |
$ | - | | |
$ | 146,630 | |
The accompanying notes
are an integral part of these consolidated financial statements.
Creatd, Inc.
December 31, 2022
Notes to the Consolidated Financial Statements
Note 1 – Organization and Operations
Creatd, Inc., formerly Jerrick Media Holdings,
Inc. (“we,” “us,” the “Company,” or “Creatd”), is a technology company focused on providing
economic opportunities for creators, which it accomplishes through its four main business pillars: Creatd Labs, Creatd Partners, Creatd
Ventures, and Creatd Studios. Creatd’s flagship product, Vocal, delivers a robust long-form, digital publishing platform organized
into highly engaged niche-communities capable of hosting all forms of rich media content. Through Creatd’s proprietary algorithm
dynamics, Vocal enhances the visibility of content and maximizes viewership, providing advertisers access to target markets that most
closely match their interests.
The Company was originally incorporated under
the laws of the State of Nevada on December 30, 1999 under the name LILM, Inc. The Company changed its name on December 3, 2013 to Great
Plains Holdings, Inc. as part of its plan to diversify its business.
On February 5, 2016 (the “Closing Date”),
GTPH, GPH Merger Sub, Inc., a Nevada corporation and wholly-owned subsidiary of GTPH (“Merger Sub”), and Jerrick Ventures,
Inc., a privately-held Nevada corporation headquartered in New Jersey (“Jerrick”), entered into an Agreement and Plan of Merger
(the “Merger”) pursuant to which the Merger Sub was merged with and into Jerrick, with Jerrick surviving as a wholly-owned
subsidiary of GTPH (the “Merger”). GTPH acquired, pursuant to the Merger, all of the outstanding capital stock of Jerrick
in exchange for issuing Jerrick’s shareholders (the “Jerrick Shareholders”), pro-rata, a total of 475,000 shares
of GTPH’s common stock. In connection therewith, GTPH acquired 33,415 shares of Jerrick’s Series A Convertible Preferred
Stock (the “Jerrick Series A Preferred”) and 8,064 shares of Series B Convertible Preferred Stock (the “Jerrick
Series B Preferred”).
In connection with the Merger, on the Closing
Date, GTPH and Kent Campbell entered into a Spin-Off Agreement (the “Spin-Off Agreement”), pursuant to which Mr. Campbell
purchased from GTPH (i) all of GTPH’s interest in Ashland Holdings, LLC, a Florida limited liability company, and (ii) all of GTPH’s
interest in Lil Marc, Inc., a Utah corporation, in exchange for the cancellation of 39,091 shares of GTPH’s Common Stock
held by Mr. Campbell. In addition, Mr. Campbell assumed all debts, obligations and liabilities of GTPH, including any existing prior to
the Merger, pursuant to the terms and conditions of the Spin-Off Agreement.
Upon closing of the Merger on February 5, 2016,
the Company changed its business plan to that of Jerrick.
Effective February 28, 2016, GTPH entered into
an Agreement and Plan of Merger (the “Statutory Merger Agreement”) with Jerrick, pursuant to which GTPH became the parent
company of Jerrick Ventures, LLC, a wholly-owned operating subsidiary of Jerrick (the “Statutory Merger”) and GTPH changed
its name to Jerrick Media Holdings, Inc. to better reflect its new business strategy.
On September 11, 2019, the Company acquired 100%
of the membership interests of Seller’s Choice, LLC, a New Jersey limited liability company (“Seller’s Choice”),
a digital e-commerce agency.
On September 9,
2020, the Company filed a certificate of amendment with the Secretary of State of the State of Nevada to change our name to “Creatd,
Inc.”, which became effective on September 10, 2020.
On June 4, 2021, the Company acquired 89%
of the membership interests of Plant Camp, LLC, a Delaware limited liability company (“Plant Camp”), which the Company subsequently
rebranded as Camp. Camp is a direct-to-consumer (DTC) food brand which creates healthy upgrades to classic comfort food favorites. The
results of Plant Camp’s operations have been included since the date of acquisition in the Statements of Operations.
On July 20, 2021, the Company acquired 44%
of the membership interests of WHE Agency, Inc. WHE Agency, Inc, is a talent management and public relations agency based in New York
(“WHE”). WHE has been consolidated due to the Company’s ownership of 55% voting control, and the results of operations
have been included since the date of acquisition in the Statements of Operations.
Between October 21, 2020, and August 16, 2021,
the Company acquired 21% of the membership interests of Dune, Inc. Dune, Inc. is a direct-to-consumer brand focused on promoting
wellness through its range of health-oriented beverages.
On October 3, 2021, the Company acquired an
additional 29% of the membership interests of Dune, Inc., bringing our total membership interests to 50%. Dune, Inc., has been consolidated
due to the Company’s ownership of 50% voting control, and the results of operations have been included since the date of acquisition
in the Statements of Operations.
On March 7, 2022, the Company acquired 100%
of the membership interests of Denver Bodega, LLC, d/b/a Basis, a Colorado limited liability company (“Basis”). Basis is a
direct-to-consumer functional beverage brand that makes high-electrolyte mixes meant to aid hydration. Denver Bodega, LLC has been consolidated
due to the Company’s ownership of 100% voting control, and the results of operations have been included since the date of acquisition
in the Statement of Operations.
On August 1, 2022, the Company acquired 51%
of the membership interests of Orbit Media LLC, a New York limited liability company. Orbit is a app-based stock trading platform designed
to empower a new generation of investors. Orbit has been consolidated due to the Company’s ownership of 51% voting control,
and the results of operations have been included since the date of acquisition in the Statement of Operations.
On September 13, 2022, the Company acquired 100%
of the membership interests of Brave Foods, LLC, a Maine limited liability company. Brave is a plant-based food company that provides
convenient and healthy breakfast food products. Brave Foods, LLC has been consolidated due to the Company’s ownership of 100%
voting control, and the results of operations have been included since the date of acquisition in the Statement of Operations.
On December 13, 2022, an investor entered into
a Subscription Agreement whereby it purchased from OG Collection, Inc., a subsidiary of the Company (“OG”), 150,000 shares
of common stock of OG for a purchase price of $750,000, and, in connection therewith OG, the Company, and the Investor entered into a
Shareholder Agreement.
Note 2 – Significant Accounting Policies
and Practices
Management of the Company is responsible for the
selection and use of appropriate accounting policies and the appropriateness of accounting policies and their application. Critical accounting
policies and practices are those that are both most important to the portrayal of the Company’s financial condition and results
and require management’s most difficult, subjective, or complex judgments, often as a result of the need to make estimates about
the effects of matters that are inherently uncertain. The Company’s significant and critical accounting policies and practices are
disclosed below as required by the accounting principles generally accepted in the United States of America.
Use of Estimates and Critical Accounting
Estimates and Assumptions
The preparation of financial statements in conformity
with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure
of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during
the reporting periods.
These significant accounting estimates or assumptions
bear the risk of change due to the fact that there are uncertainties attached to these estimates or assumptions, and certain estimates
or assumptions are difficult to measure or value.
Management bases its estimates on historical experience
and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances,
the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent
from other sources.
Management regularly evaluates the key factors
and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical
experience and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. The Company
uses estimates in accounting for, among other items, revenue recognition, allowance for doubtful accounts, stock-based compensation, income
tax provisions, excess and obsolete inventory reserve, and impairment of intellectual property.
Actual results could differ from those estimates.
Principles of consolidation
The Company consolidates all majority-owned subsidiaries,
if any, in which the parent’s power to control exists.
As of December 31, 2022, the Company’s consolidated
subsidiaries and/or entities are as follows:
Name of combined affiliate | |
State or other jurisdiction of incorporation or organization | |
Company Ownership Interest | |
Jerrick Ventures LLC | |
Delaware | |
| 100 | % |
Abacus Tech Pty Ltd | |
Australia | |
| 100 | % |
Creatd Ventures LLC | |
Delaware | |
| 100 | % |
Dune Inc. | |
Delaware | |
| 50 | % |
OG Collection, Inc. | |
Delaware | |
| 89 | % |
Orbit Media LLC | |
New York | |
| 51 | % |
WHE Agency, Inc. | |
Delaware | |
| 44 | % |
As of December 31, 2022, Creatd Ventures, LLC
(formerly Creatd Partners, LLC) is operating three DBAs for Brave Foods, Plant Camp, and Basis (formerly Denver Bodega, LLC).
All other previously consolidated subsidiaries
have been dissolved.
All inter-company balances and transactions have
been eliminated. The consolidated financial statements include Denver Bodega, LLC activity since March 7, 2022, Orbit Media LLC activity
since August 1, 2022, and Brave Foods, LLC activity since September 13, 2022.
Variable Interest Entities
Management performs an ongoing assessment of its
noncontrolling interests from investments in unrelated entities to determine if those entities are variable interest entities (VIEs),
and if so, whether the Company is the primary beneficiary. If an entity in such a transaction, by design, meets the definition of a VIE
and the Company determines that it, or a consolidated subsidiary is the primary beneficiary, the Company will include the VIE in its consolidated
financial statements. If such an entity is deemed to not be consolidated, the Company records only its investment in equity securities
as a marketable security or investment under the equity method, as applicable.
Fair Value of Financial Instruments
The fair value measurement disclosures are grouped
into three levels based on valuation factors:
|
● |
Level 1 – quoted prices in active markets for identical investments |
|
● |
Level 2 – other significant observable inputs (including quoted prices for similar investments and market corroborated inputs) |
|
● |
Level 3 – significant unobservable inputs (including our own assumptions in determining the fair value of investments) |
The Company’s Level 1 assets/liabilities
include cash, accounts receivable, marketable trading securities, accounts payable, marketable trading securities, prepaid and other current
assets, line of credit and due to related parties. Management believes the estimated fair value of these accounts at December 31, 2022
approximate their carrying value as reflected in the balance sheets due to the short-term nature of these instruments or the use of market
interest rates for debt instruments.
The Company’s Level 2 assets/liabilities
include certain of the Company’s notes payable. Their carrying value approximates their fair values based upon a comparison of the
interest rate and terms of such debt given the level of risk to the rates and terms of similar debt currently available to the Company
in the marketplace.
The Company’s Level 3 assets/liabilities
include goodwill, intangible assets, equity investments at cost, and derivative liabilities. Inputs to determine fair value are generally
unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset
or liability. The fair values are therefore determined using model-based techniques, including option pricing models and discounted cash
flow models. Unobservable inputs used in the models are significant to the fair values of the assets and liabilities.
The following tables provide a summary of the
relevant assets that are measured at fair value on a recurring basis:
Fair Value Measurements as of
December 31, 2021
| |
Total | | |
Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1) | | |
Quoted Prices for Similar Assets or Liabilities in Active Markets (Level 2) | | |
Significant Unobservable Inputs (Level 3) | |
Assets: | |
| | |
| | |
| | |
| |
Marketable securities - debt securities | |
$ | - | | |
$ | - | | |
$ | - | | |
$ | - | |
Total assets | |
$ | - | | |
$ | - | | |
$ | - | | |
$ | - | |
| |
| | | |
| | | |
| | | |
| | |
Liabilities: | |
| | | |
| | | |
| | | |
| | |
Derivative liabilities | |
$ | - | | |
$ | - | | |
$ | - | | |
$ | - | |
Total Liabilities | |
| - | | |
$ | - | | |
$ | - | | |
$ | - | |
Fair Value Measurements as of
December 31, 2022
| |
Total | | |
Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1) | | |
Quoted Prices for Similar Assets or Liabilities in Active Markets (Level 2) | | |
Significant Unobservable Inputs (Level 3) | |
Assets: | |
| | | |
| | | |
| | | |
| | |
Marketable securities - equity securities | |
$ | - | | |
$ | - | | |
$ | - | | |
$ | - | |
Total assets | |
$ | - | | |
$ | - | | |
$ | - | | |
$ | - | |
Our marketable equity securities are publicly
traded stocks measured at fair value using quoted prices for identical assets in active markets and classified as Level 1 within the fair
value hierarchy. Marketable equity securities as of December 31, 2022 and 2021 are $0.
The change in net realized depreciation on equity
trading securities that have been included in other expenses for the year ended December 31, 2022 and 2021 was $11,742 and $0, respectively.
The following table sets forth a summary of the
changes in marketable securities - available-for-sale debt securities that are measured at fair value on a recurring basis:
| |
For the years ended December 31, 2022 and 2021 | |
| |
Total | |
As of January 1, 2021 | |
$ | 62,733 | |
Purchase of marketable securities | |
| - | |
Interest due at maturity | |
| - | |
Other than temporary impairment | |
| (62,733 | ) |
Conversion of marketable securities | |
| - | |
December 31, 2021 and 2022 | |
$ | - | |
The following are the changes in the derivative
liabilities during the years ended December 31, 2022 and 2021.
| |
Years Ended December 31, 2022 and 2021 | |
| |
Level 1 | | |
Level 2 | | |
Level 3 | |
Derivative liabilities as January 1, 2021 | |
$ | - | | |
$ | - | | |
$ | 42,231 | |
Addition | |
| - | | |
| - | | |
| 417,24 | |
Extinguishment | |
| - | | |
| - | | |
| (431,458 | ) |
Conversion to Note payable - related party | |
| - | | |
| - | | |
| (1,124,301 | ) |
Changes in fair value | |
| - | | |
| - | | |
| 1,096,287 | |
Derivative liabilities as December 31, 2021 | |
| - | | |
| - | | |
| - | |
Addition | |
| - | | |
| - | | |
| 100,532 | |
Changes in fair value | |
| - | | |
| - | | |
| (3,729 | ) |
Extinguishment | |
| - | | |
| - | | |
| (96,803 | ) |
Derivative liabilities as December 31, 2022 | |
$ | - | | |
$ | - | | |
$ | - | |
The following tables provide a summary of the
relevant assets that are measured at fair value on a non-recurring basis:
Fair Value Measurements as of
December 31, 2021
| |
Total | | |
Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1) | | |
Quoted Prices for Similar Assets or Liabilities in Active Markets (Level 2) | | |
Significant Unobservable Inputs (Level 3) | |
Assets: | |
| | |
| | |
| | |
| |
Equity investments, at cost | |
$ | 50,000 | | |
$ | - | | |
$ | - | | |
$ | 50,000 | |
Intangible assets | |
| 2,432,841 | | |
| - | | |
| - | | |
| 2,432,841 | |
Goodwill | |
| 1,374,835 | | |
| - | | |
| - | | |
| 1,374,835 | |
Total assets | |
$ | 3,857,676 | | |
$ | - | | |
$ | - | | |
$ | 3,857,676 | |
Fair Value Measurements as of
December 31, 2022
| |
Total | | |
Quoted Prices in Active Markets for Identical Assets or Liabilities (Level 1) | | |
Quoted Prices for Similar Assets or Liabilities in Active Markets (Level 2) | | |
Significant Unobservable Inputs (Level 3) | |
Assets: | |
| | |
| | |
| | |
| |
Equity investments, at cost | |
$ | - | | |
$ | - | | |
$ | - | | |
$ | - | |
Intangible assets | |
| 230,084 | | |
| - | | |
| - | | |
| 230,084 | |
Goodwill | |
| 46,460 | | |
| - | | |
| - | | |
| 46,460 | |
Total assets | |
$ | 276,544 | | |
$ | - | | |
$ | - | | |
$ | 276,544 | |
Cash Equivalents
The Company considers all highly liquid investments
with a maturity of three months or less when purchased to be cash equivalents.
At times, cash balances may exceed the Federal
Deposit Insurance Corporation (“FDIC”) or Financial Claims Scheme (“FCS”) insurable limits. The Company has never
experienced any losses related to these balances. The uninsured cash balance as of December 31, 2022, was $308,474. The Company does not
believe it is exposed to significant credit risk on cash and cash equivalents.
Concentration of Credit Risk and Other Risks
and Uncertainties
The Company provides credit in the normal course
of business. The Company maintains allowances for credit losses on factors surrounding the credit risk of specific customers, historical
trends, and other information.
The Company operates in Australia and holds total
assets of $700,268. It is reasonably possible that operations located outside an entity’s home country will be disrupted in
the near term.
Property and Equipment
Property and equipment are recorded at cost. Expenditures
for major additions and betterments are capitalized. Maintenance and repairs are charged to operations as incurred. Depreciation is computed
by the straight-line method (after taking into account their respective estimated residual values) over the estimated useful lives of
the respective assets as follows:
|
|
Estimated
Useful Life
(Years) |
|
|
|
|
|
Computer equipment and software |
|
3 |
|
Furniture and fixtures |
|
5 |
|
Leasehold Improvements |
|
3 |
|
Upon sale or retirement of property and equipment,
the related cost and accumulated depreciation are removed from the accounts and any gain or loss is reflected in the consolidated statements
of operations.
Long-lived Assets Including Acquired Intangible
Assets
We evaluate the recoverability of property and equipment, acquired
finite-lived intangible assets and, purchased infinite life digital assets for possible impairment whenever events or circumstances indicate
that the carrying amount of such assets may not be recoverable. The evaluation is performed at the lowest level for which identifiable
cash flows are largely independent of the cash flows of other assets and liabilities. Recoverability of these assets is measured by a
comparison of the carrying amounts to the future undiscounted cash flows the assets are expected to generate from the use and eventual
disposition. Digital assets accounted for as intangible assets are subject to impairment losses if the fair value of digital assets decreases
other than temporarily below the carrying value. The fair value is measured using the quoted price of the crypto asset at the time its
fair value is being measured. If such review indicates that the carrying amount of property and equipment and intangible assets is not
recoverable, the carrying amount of such assets is reduced to fair value. During the year ended December 31, 2022, the Company recorded
an impairment charge of $2,043,111 for intangible assets. During the year ended December 31, 2021, the Company recorded an impairment
charge of $688,127 for intangible assets.
Acquired finite-lived intangible assets are amortized
on a straight-line basis over the estimated useful lives of the assets. We routinely review the remaining estimated useful lives of property
and equipment and finite-lived intangible assets. If we change the estimated useful life assumption for any asset, the remaining unamortized
balance is amortized or depreciated over the revised estimated useful life. The remaining weighted average life of the intangible assets
is 8.06 years.
Scheduled amortization over the next five years are as follows: |
Twelve months ending December 31,
2023 | |
$ | 32,097 | |
2024 | |
| 32,098 | |
2025 | |
| 28,863 | |
2026 | |
| 18,966 | |
2027 | |
| 18,964 | |
Thereafter | |
| 76,313 | |
Total | |
| 207,301 | |
| |
| | |
Intangible assets not subject to amortization | |
| 22,783 | |
Total Intangible Assets | |
$ | 230,084 | |
Amortization expense was $483,484 and
$348,186 for the year ended December 31, 2022 and 2021, respectively.
Goodwill
Goodwill is not amortized but is subject to periodic
testing for impairment in accordance with ASC Topic 350 “Intangibles – Goodwill and Other – Testing Indefinite-Lived
Intangible Assets for Impairment” (“ASC Topic 350”). The Company tests goodwill for impairment on an annual basis as
of the last day of the Company’s fiscal December each year or more frequently if events occur or circumstances change indicating
that the fair value of the goodwill may be below its carrying amount. The Company uses an income-based approach to determine the fair
value of the reporting units. This approach uses a discounted cash flow methodology and the ability of our reporting units to generate
cash flows as measures of fair value of our reporting units.
During the year ended December 31, 2022 and 2021, the Company completed
its annual impairment tests of goodwill. The Company performed the qualitative assessment as permitted by ASC 350-20 and determined for
one of its reporting units that the fair value of that reporting unit was more likely than not greater than its carrying value, including
Goodwill. However, based on this qualitative assessment, the Company determined that the carrying value of the Denver Bodega, Dune, Plant
Camp and, WHE Agency reporting units was more likely than not greater than their carrying value, including Goodwill. Based on the completion
of the annual impairment tests, the Company recorded an impairment charge of $1,433,815 and $1,035,795 for goodwill for the years ended
December 31 2022 and 2021, respectively.
The following table sets forth a summary of the
changes in goodwill for the years ended December 31, 2021 and 2022.
| |
For the years ended December 31, 2021 and 2022 | |
| |
Total | |
As of January 1, 2021 | |
$ | 1,035,795 | |
Goodwill acquired in a business combination | |
| 1,374,835 | |
Impairment of goodwill | |
| (1,035,795 | ) |
As of December 31, 2021 | |
| 1,374,835 | |
Goodwill acquired in business combinations | |
| 105,440 | |
Impairment of goodwill | |
| (1,433,815 | ) |
As of December 31, 2022 | |
| 46,460 | |
Investments
Marketable securities that are bought and held
principally for the purpose of selling them in the near term are classified as trading securities and are reported at fair value, with
unrealized gains and losses recognized in earnings. Debt securities not classified as held-to-maturity or as trading are classified as
available-for-sale, and are carried at fair market value, with the unrealized gains and losses, net of tax, included in the determination
of comprehensive income and reported in stockholders’ equity.
The Company accounts for its investments in available-for-sale
debt securities, in accordance with sub-topic 320-10 of the FASB ASC (“Sub-Topic 320-10”). Accrued interest on these securities
is included in fair value and amortized cost.
Pursuant to Paragraph 320-10-35, investments in
debt securities that are classified as available for sale shall be measured subsequently at fair value in the statement of financial position.
Unrealized holding gains and losses for available-for-sale securities (including those classified as current assets) shall be excluded
from earnings and reported in other comprehensive income until realized.
The Company follows FASB ASC 320-10-35 to assess
whether an investment in debt securities is impaired in each reporting period. An investment in debt securities is impaired if the fair
value of the investment is less than its amortized cost. If the Company intends to sell the debt security (that is, it has decided to
sell the security), an other-than-temporary impairment shall be considered to have occurred. If the Company more likely than not will
be required to sell the security before recovery of its amortized cost basis or it otherwise does not expect to recover the entire amortized
cost basis of the security, an other-than-temporary impairment shall be considered to have occurred. The Company considers the expected
cash flows from the investment based on reasonable and supportable forecasts as well as several other factors to estimate whether a credit
loss exists. If the Company intends to sell the security or more likely than not will be required to sell the security before recovery
of its amortized cost basis less any current-period credit loss, the other-than-temporary impairment shall be recognized in earnings equal
to the entire difference between the investment’s amortized cost basis and its fair value at the balance sheet date.
The following table sets forth a summary of the
changes in marketable securities - available-for-sale debt securities that are measured at fair value on a recurring basis:
| |
For the years ended December 31, 2022 and 2021 | |
| |
Total | |
As of January 1, 2021 | |
$ | 62,733 | |
Purchase of marketable securities | |
| - | |
Interest due at maturity | |
| - | |
Other than temporary impairment | |
| (62,733 | ) |
Conversion of marketable securities | |
| - | |
December 31, 2021 and 2022 | |
$ | - | |
We invest in debt securities. Our investments
in debt securities are subject to interest rate risk. To minimize the exposure due to an adverse shift in interest rates, we invest in
securities with maturities of two years or less and maintain a weighted average maturity of one year or less. As of December 31, 2021,
all of our investments had maturities between one and three years. The marketable debt security investments are evaluated for impairment
if events or circumstances arise that indicate that the carrying amount of such assets may not be recoverable. During the years ended
December 31, 2021, the Company recognized a $62,733 from the impairment of the debt security.
The following table sets forth a summary of the
changes in equity investments, at cost that are measured at fair value on a non-recurring basis:
| |
For the years ended December 31, 2021 and 2022 | |
| |
Total | |
As of January 1, 2021 | |
$ | 217,096 | |
Purchase of equity investments | |
| 150,000 | |
Other than temporary impairment | |
| (102,096 | ) |
Conversion to equity method investments | |
| (215,000 | ) |
As of December 31, 2021 | |
| 50,000 | |
Purchase of equity investments | |
| - | |
Other than temporary impairment | |
| (50,000 | ) |
Conversion to equity method investments | |
| - | |
As of December 31, 2022 | |
$ | - | |
The Company has elected to measure its equity
securities without a readily determinable fair value at cost minus impairment, if any, plus or minus changes resulting from observable
price changes in orderly transactions for the identical or a similar investment of the same issuer. An election to measure an equity security
in accordance with this paragraph shall be made for each investment separately.
The Company performed a qualitative assessment
considering impairment indicators to evaluate whether these investments were impaired. Impairment indicators that the Company considered
included the following: a) a significant deterioration in the earnings performance, credit rating, asset quality or business prospects
of the investee; b) a significant adverse change in the regulatory, economic or technology environment of the investee; c) a significant
adverse change in the general market condition of either the geographical area or the industry in which the investee operates; d) a bona
fide offer to purchase or an offer by the investee to sell the investment; e) factors that raise significant concerns about the investee’s
ability to continue as a going concern. During the years ended December 31, 2022 and 2021 the Company recognized a $50,000 and $102,096
impairment of the equity security respectively.
Equity Method Investments
Investments in unconsolidated entities over which
we have significant influence are accounted for under the equity method of accounting. Under the equity method of accounting, the Company
does not consolidate the investment’s financial statements within its consolidated financial statements. Equity method investments
are initially recorded at cost, then our proportional share of the underlying net income or loss is recorded as equity in net loss from
equity method investments in our statement of operations, with a corresponding increase or decrease to the carrying value of the investment.
Distributions received from the investee reduce our carrying value of the investment and are recorded in the consolidated statements of
cash flows using the cumulative earnings approach. These investments are evaluated for impairment if events or circumstances arise that
indicate that the carrying amount of such assets may not be recoverable. There were indicators of impairment related to our equity method
investments for the year ended December 31, 2021. During the year ended December 31, 2022 and 2021, the Company recorded an impairment
charge of $50,000 and $487,365 respectively for equity method investments.
Commitments and Contingencies
The Company follows subtopic 450-20 of the FASB
ASC to report accounting for contingencies. Certain conditions may exist as of the date the consolidated financial statements are issued,
which may result in a loss to the Company, but which will only be resolved when one or more future events occur or fail to occur. The
Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies
related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company
evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief
sought or expected to be sought therein.
If the assessment of a contingency indicates that
it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would
be accrued in the Company’s consolidated financial statements. If the assessment indicates that a potential material loss contingency
is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an
estimate of the range of possible losses, if determinable and material, would be disclosed.
Loss contingencies considered remote are generally
not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.
Foreign Currency
Foreign currency denominated assets and liabilities
are translated into U.S. dollars using the exchange rates in effect at our Consolidated Balance Sheet dates. Results of operations and
cash flows are translated using the average exchange rates throughout the periods. The effect of exchange rate fluctuations on the translation
of assets and liabilities is included as a component of stockholders’ equity in accumulated other comprehensive income. Gains and
losses from foreign currency transactions, which are included in operating expenses, have not been significant in any period presented.
Derivative Liability
The Company evaluates its debt and equity issuances
to determine if those contracts or embedded components of those contracts qualify as derivatives to be separately accounted for in accordance
with paragraph 815-10-05-4 and Section 815-40-25 of the FASB Accounting Standards Codification. The result of this accounting treatment
is that the fair value of the embedded derivative is marked-to-market each balance sheet date and recorded as either an asset or a liability.
In the event that the fair value is recorded as a liability, the change in fair value is recorded in the consolidated statement of operations
as other income or expense. Upon conversion, exercise or cancellation of a derivative instrument, the instrument is marked to fair value
at the date of conversion, exercise or cancellation and then the related fair value is reclassified to equity.
In circumstances
where the embedded conversion option in a convertible instrument is required to be bifurcated and there are also other embedded derivative
instruments in the convertible instrument that are required to be bifurcated, the bifurcated derivative instruments are accounted for
as a single, compound derivative instrument.
The classification of derivative instruments,
including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period.
Equity instruments that are initially classified as equity that become subject to reclassification are reclassified to liability at the
fair value of the instrument on the reclassification date. Derivative instrument liabilities will be classified in the balance sheet as
current or non-current based on whether or not net-cash settlement of the derivative instrument is expected within 12 months of the balance
sheet date.
The Company adopted Section 815-40-15 of the FASB
Accounting Standards Codification (“Section 815-40-15”) to determine whether an instrument (or an embedded feature) is indexed
to the Company’s own stock. Section 815-40-15 provides that an entity should use a two-step approach to evaluate whether an
equity-linked financial instrument (or embedded feature) is indexed to its own stock, including evaluating the instrument’s contingent
exercise and settlement provisions.
The Company utilizes a binomial option model for
convertible notes that have an option to convert at a variable number of shares to compute the fair value of the derivative and to mark
to market the fair value of the derivative at each balance sheet date. The inputs utilized in the application of the Binomial model included
a stock price on valuation date, an expected term of each debenture remaining from the valuation date to maturity, an estimated volatility,
and a risk-free rate. The Company records the change in the fair value of the derivative as other income or expense in the consolidated
statements of operations.
Shipping and Handling Costs
The Company classifies freight billed to customers
as sales revenue and the related freight costs as cost of revenue.
Revenue Recognition
Under Topic 606, revenue is recognized when control
of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled
to in exchange for those goods or services.
We determine revenue recognition through the following
steps:
|
● |
identification of the contract, or contracts, with a customer; |
|
● |
identification of the performance obligations in the contract; |
|
● |
determination of the transaction price. The transaction price for any given subscriber could decrease based on any payments made to that subscriber. A subscriber may be eligible for payment through one or more of the monetization features offered to Vocal creators, including earnings through reads (on a cost per mile basis) and cash prizes offered to Challenge winners; |
|
● |
allocation of the transaction price to the performance obligations in the contract; and |
|
● |
recognition of revenue when, or as, we satisfy a performance obligation. |
Revenue disaggregated by revenue source for the
year ended December 30, 2022 and 2021 consists of the following:
| |
Years Ended | |
| |
December 31, | |
| |
2022 | | |
2021 | |
Agency (Managed Services, Branded Content, & Talent Management Services) | |
$ | 1,914,647 | | |
$ | 2,256,546 | |
Platform (Creator Subscriptions) | |
| 1,417,094 | | |
| 1,926,135 | |
Ecommerce | |
| 1,457,161 | | |
| 90,433 | |
Affiliate Sales | |
| 7,572 | | |
| 26,453 | |
Other Revenue | |
| - | | |
| 150 | |
| |
$ | 4,796,474 | | |
$ | 4,299,717 | |
The Company utilizes the output method to measures
the results achieved and value transferred to a customer over time. Timing of revenue recognition for the three and years ended December
31, 2022 and 2021 consists of the following:
| |
Years Ended | |
| |
December 31, | |
| |
2022 | | |
2021 | |
Products and services transferred over time | |
$ | 3,331,741 | | |
$ | 4,182,681 | |
Products transferred at a point in time | |
| 1,464,733 | | |
| 117,036 | |
| |
$ | 4,796,474 | | |
$ | 4,299,717 | |
Agency Revenue
Managed Services
The Company provides Studio/Agency Service offerings
to business-to-business (B2B) and business-to-consumer (B2C) product and service brands which encompasses a full range of digital marketing
and e-commerce solutions. The Company’s services include the setup and ongoing management of clients’ websites, Amazon and
Shopify storefronts and listings, social media pages, search engine marketing, and other various tools and sales channels utilized by
e-commerce sellers for sales and growth optimization. Contracts are broken into three categories: Partners, Monthly Services, and Projects.
Contract amounts for Partner and Monthly Services clients range from approximately $500-$7,500 per month while Project amounts vary
depending on the scope of work. Partner and Monthly clients are billed monthly for the work completed within that month. Partner Clients
may or may not have an additional billing component referred to as Sales Performance Fee, which is a fee based upon a previously agreed
upon percentage point of the client’s total sales for the month. Some Partners may also have projects within their contracts that
get billed and recognized as agreed upon project milestones are achieved. Revenue is recognized over time as service obligations and milestones
in the contract are met.
Branded Content
Branded content
represents the revenue recognized from the Company’s obligation to create and publish branded articles and/or branded challenges
for clients on the Vocal platform and promote said stories, tracking engagement for the client. In the case of branded articles, the performance
obligation is satisfied when the Company successfully publishes the articles on its platform and meets any required promotional milestones
as per the contract. In the case of branded challenges, the performance obligation is satisfied when the Company successfully closes the
challenge and winners have been announced. The Company utilizes the completed contract method when revenue is recognized over time as
the services are performed and any required milestones are met. Certain contracts contain separate milestones whereas the Company separates
its performance obligations and utilizes the stand-alone selling price method and residual method to determine the estimate of the allocation
of the transaction price.
Below are the significant components of a typical
agreement pertaining to branded content revenue:
| ● | The Company collects fixed fees ranging from $10,000 to $110,000, with branded challenges ranging from $10,000 to $25,000 and branded articles ranging from $2,500 to $10,000 per article. |
| ● | Branded articles are created and published, and challenges are completed, within three months of the signed agreement, or as previously negotiated with the client. |
|
● |
Branded articles and challenges are promoted per the contract and engagement reports are provided to the client. |
|
● |
Most contracts include provisions for clients to acquire content rights at the end of the campaign for a flat fee. |
Talent Management Services
Talent Management represents the revenue recognized
by WHE Agency, Inc. (“WHE”) from the Company’s obligation to manage and oversee influencer-led campaigns from the contract
negotiation stage through content creation and publication. WHE acts in an agent capacity for influencers and collects a management fee
of approximately 20% of the value of an influencer’s contract with a brand. Revenue is recognized net of the 80% of the
contract that is collected by the influencer and is recognized when performance obligations of the contract are met. Performance obligations
are complete when milestones and deliverables of contracts are delivered to the client.
Below are the significant components of a typical
agreement pertaining to talent management revenue:
| ● | Total gross contracts range from $500-$100,000. |
| ● | The Company collects fixed fees in the amount of 20 to 25% of the gross contract amount, ranging from $100 to $25,000 in net revenue per contract. |
|
● |
The campaign is created and made live by the influencer within the timeframe specified in the contract. |
|
● |
Campaigns are promoted per the contract and the customer is provided a link to the live deliverables on the influencer’s social media channels. |
| ● | Most billing for contracts occur 100% at execution of the performance obligation. Net payment terms vary by client. |
Platform Revenue
Creator Subscriptions
Vocal+ is a premium
subscription offering for Vocal creators. In addition to joining for free, Vocal creators now have the option to sign up for a Vocal+
membership for either $9.99 monthly or $99 annually, though these amounts are subject to promotional discounts and free trials.
Vocal+ subscribers receive access to value-added features such as increased rate of cost per mille (thousand) (“CPM”) monetization,
a decreased minimum withdrawal threshold, a discount on platform processing fees, member badges for their profiles, access to exclusive
Vocal+ Challenges, and early access to new Vocal features. Subscription revenues stem from both monthly and annual subscriptions, the
latter of which is amortized over a twelve-month period. Any customer payments received are recognized over the subscription period, with
any payments received in advance being deferred until they are earned.
The transaction price for any given subscriber
could decrease based on any payments made to that subscriber. A subscriber may be eligible for payment through one or more of the monetization
features offered to Vocal creators, including earnings through reads (on a cost per mille basis) and cash prizes offered to Challenge
winners. Potential revenue offset is calculated by reviewing a subscriber’s earnings in conjunction with payments made by the subscriber
on a monthly and/or annual basis.
Affiliate Sales Revenue
Affiliate sales represents the commission the Company
receives from views or sales of its multimedia assets. Affiliate revenue is earned on a “click through” basis, upon visitors
viewing or purchasing the relevant video, book, or other media asset and completing a specific conversion. The revenue is recognized upon
receipt as reliable estimates could not be made.
E-Commerce Revenue
The Company’s e-commerce businesses are
housed under Creatd Ventures, and currently consists of four majority-owned e-commerce companies, Camp (previously Plant Camp), Dune Glow
Remedy (“Dune”), Basis, and Brave. The Company generates revenue through the sale of Camp, Dune, Basis, and Brave’s
consumer products through its e-commerce distribution channels. The Company satisfies its performance obligation upon shipment of product
to its customers and recognizes shipping and handling costs as a fulfillment cost. Customers have 30 days from receipt of an item
to return unopened, unused, or damaged items for a full refund for Camp, Dune, and Basis, and 7 days from receipt of purchase for Brave.
All returns are processed within the relevant recording period and accounted for as a reduction in revenue. The Company runs discounts
from time to time to promote sales, improve market penetration, and increase customer retention. Any discounts are run as coupon codes
applied at the time of transaction and accounted for as a reduction in gross revenue. The Company assesses variable consideration using
the most likely amount method.
Deferred Revenue
Deferred revenue consists of billings and payments
from clients in advance of revenue recognition. The Company has two types of deferred revenue, subscription revenue whereas the revenue
is recognized over the subscription period and contract liabilities where the performance obligation was not satisfied. The Company will
recognize the deferred revenue within the next twelve months. As of December 31, 2022, and 2021, the Company had deferred revenue of $299,409
and $234,159 respectively.
Accounts Receivable and Allowances
Accounts receivable are recorded and carried when
the Company has performed the work in accordance with managed services, project, partner, consulting and branded content agreements. For
example, we bill a managed service client monthly when we have updated their Amazon store, modified SEO, or completed the other services
listed in the agreement. For projects and branded content, we will bill the client and record the receivable once milestones are reached
that are set in the agreement. We make estimates for the allowance for doubtful accounts and allowance for unbilled receivables based
upon our assessment of various factors, including historical experience, the age of the accounts receivable balances, credit quality of
our customers, current economic conditions, and other factors that may affect our ability to collect from customers. During the years
ended December 31, 2022 and 2021, the Company recorded $398,130 and $110,805, respectively as a bad debt expense. As of December 31, 2022,
the Company has an allowance for doubtful accounts of $585,077. As of December 31, 2021, the Company has an allowance for doubtful accounts
of $186,147.
Inventory
Inventories are stated at the lower of cost (first-in,
first-out basis) or net realizable value. Inventories are periodically evaluated to identify obsolete or otherwise impaired products and
are written off when management determines usage is not probable. The Company estimates the balance of excess and obsolete inventory by
analyzing inventory by age using last used and original purchase date and existing sales pipeline for which the inventory could be used.
As of December 31, 2022, and 2021, the Company had a valuation allowance of $399.058 and $0 respectively. During the years ended December
31, 2022 and 2021 the Company recorded $399,058 and $0 respectively for product obsolescence.
Stock-Based Compensation
The Company recognizes compensation expense for all
equity–based payments granted in accordance with Accounting Standards Codification (“ASC”) 718 “Compensation –
Stock Compensation”. Under fair value recognition provisions, the Company recognizes equity–based compensation over the requisite
service period of the award. The company has a relatively low forfeiture rate of stock-based compensation and forfeitures are recognized
as they occur.
Restricted stock awards are granted at the discretion
of the Company. These awards are restricted as to the transfer of ownership and generally vest over the requisite service periods.
The fair value of an option award is estimated
on the date of grant using the Black–Scholes option valuation model. The Black–Scholes option valuation model requires the
development of assumptions that are inputs into the model. These assumptions are the value of the underlying share, the expected stock
volatility, the risk–free interest rate, the expected life of the option, the dividend yield on the underlying stock and forfeitures
are recognized as they occur. . Expected volatility is derived from the Company’s historical data over the expected option life
and other appropriate factors. Risk–free interest rates are calculated based on continuously compounded risk–free rates for
the appropriate term. The dividend yield is assumed to be zero as the Company has never paid or declared any cash dividends on its Common
stock and does not intend to pay dividends on its Common stock in the foreseeable future. Forfeitures are recognized as they occur.
Determining the appropriate fair value model
and calculating the fair value of equity–based payment awards requires the input of the subjective assumptions described above.
The assumptions used in calculating the fair value of equity–based payment awards represent management’s best estimates,
which involve inherent uncertainties and the application of management’s judgment. As a result, if factors change and the Company
uses different assumptions, our equity–based compensation could be materially different in the future. The Company issues awards
of equity instruments, such as stock options and restricted stock units, to employees and certain non-employee directors. Compensation
expense related to these awards is based on the fair value of the underlying stock on the award date and is amortized over the service
period, defined as the vesting period. The vesting period is generally one to three years. A Black-Scholes model is utilized to estimate
the fair value of stock options, while the market price of the Company’s common stock at the date of grant is used for restricted
stock units. Compensation expense is reduced for actual forfeitures as they occur.
Loss Per Share
Basic net loss per common share is computed by
dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted
net loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for
the dilutive effect of common stock equivalents. For the years ended December 31, 2022 and 2021, the weighted-average number of common
shares outstanding excludes common stock equivalents because their inclusion would be anti-dilutive.
The Company had the following common stock equivalents
at December 31, 2022 and 2021:
| |
December 31, | |
| |
2022 | | |
2021 | |
Series E preferred | |
| 109,223 | | |
| 121,359 | |
Options | |
| 3,061,767 | | |
| 2,902,619 | |
Warrants | |
| 16,261,699 | | |
| 5,658,830 | |
Convertible notes | |
| 27,823,250 | | |
| - | |
Totals | |
| 47,255,939 | | |
| 8,682,808 | |
Reclassifications
Certain prior year amounts in the consolidated
financial statements and the notes thereto have been reclassified where necessary to conform to the current year’s presentation.
These reclassifications did not affect the prior period’s total assets, total liabilities, stockholders’ deficit, net loss
or net cash used in operating activities. During the year ended December 31, 2021, we adopted a change in presentation on our consolidated
statements of operations and comprehensive loss in order to present a gross profit line, the presentation of which is consistent with
our peers. Under the new presentation, we began allocating payroll and related expenses, professional services and creator payouts. Prior
periods have been revised to reflect this change in presentation.
Recently Adopted Accounting Guidance
In May 2021, the FASB issued authoritative guidance
intended to clarify and reduce diversity in an issuer’s accounting for modifications or exchanges of freestanding equity-classified
written call options that remain equity classified after modification or exchange. (ASU 2021-04), “Derivatives and Hedging Contracts
in Entity’s Own Equity (Topic 815). This guidance’s amendments provide measurement, recognition, and disclosure guidance for
an issuer’s accounting for modifications or exchanges of freestanding equity-classified written call options that remain equity
classified after modification or exchange. The updated guidance, which became effective for fiscal years beginning after December 15,
2021, During the year ended December 31, 2022, the Company recognized a deemed dividend of $3,187,906 from the modification of warrants.
Recent Accounting Guidance Not Yet Adopted
In June 2016, the FASB issued ASU No. 2016-13,
Financial Instruments – Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments (“ASU-2016-13”).
ASU 2016-13 affects loans, debt securities, trade receivables, and any other financial assets that have the contractual right to receive
cash. The ASU requires an entity to recognize expected credit losses rather than incurred losses for financial assets. On October 16,
2019, FASB approved a final ASU delaying the effective date of ASU 2016-13 for small reporting companies to interim and annual periods
beginning after December 15, 2022. The Company is currently evaluating the impact of these amendments to the Company’s financial
position and results of operations and currently does not know or cannot reasonably quantify the impact of the adoption of the amendments
as a result of the complexity and extensive changes from the amendments. The adoption of the guidance will affect disclosures and estimates
around accounts receivable.
In August 2020, the FASB issued ASU 2020-06, Debt—Debt
with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic
815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This ASU amends the guidance on convertible
instruments and the derivatives scope exception for contracts in an entity’s own equity, and also improves and amends the related
EPS guidance for both Subtopics. ASU 2020-06 is effective for the fiscal year beginning after December 15, 2022, including interim periods
within that fiscal year. Upon adoption, the Company would no longer recognize the intrinsic value of beneficial conversion features underlying
convertible debt. During the year ended December 31, 2022, the company recognized approximately $2.0 million relating to a beneficial
conversion feature.
In October 2021, the FASB issued ASU No. 2021-08,
Business Combinations — Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (Topic 805), Which
aims to improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in recognition
and payment terms that effect subsequent revenue recognition. ASU 2021-08 is effective for the fiscal year beginning after December 15,
2022, including interim periods within that fiscal year. The Company expects that there would be no material impact on the Company’s
consolidated financial statements upon the adoption of this ASU.
Management does not believe that any recently
issued, but not yet effective accounting pronouncements, when adopted, will have a material effect on the accompanying consolidated financial
statements.
Note 3 – Going Concern
The Company’s consolidated financial statements
have been prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets,
and liquidation of liabilities in the normal course of business.
As reflected in the consolidated financial statements,
as of December 31, 2022, the Company had an accumulated deficit of $146.2 million, a net loss of $35.7 million and net cash
used in operating activities of $16.7 million for the reporting period then ended. These factors raise substantial doubt about the
Company’s ability to continue as a going concern for a period of one year from the issuance of these financial statements.
The Company is attempting to further implement
its business plan and generate sufficient revenues; however, its cash position may not be sufficient to support its daily operations.
While the Company believes in the viability of its strategy to further implement its business plan and generate sufficient revenues and
in its ability to raise additional funds by way of a public or private offering of its debt or equity securities, there can be no assurance
that it will be able to do so on reasonable terms, or at all. The ability of the Company to continue as a going concern is dependent
upon its ability to further implement its business plan and generate sufficient revenues and its ability to raise additional funds by
way of a public or private offering.
The consolidated financial statements do not
include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification
of liabilities that might be necessary should the Company be unable to continue as a going concern.
Note 4 – Inventory
Inventory was comprised of the following at December
31, 2022 and December 31, 2021:
|
|
December 31,
2022 |
|
|
December 31,
2021 |
|
Raw Materials |
|
$ |
- |
|
|
$ |
- |
|
Packaging |
|
|
34,632 |
|
|
|
2,907 |
|
Finished goods |
|
$ |
370,335 |
|
|
|
103,496 |
|
|
|
$ |
404,970 |
|
|
$ |
106,403 |
|
Note 5 – Property and Equipment
Property and equipment stated at cost, less accumulated depreciation,
consisted of the following:
| |
December 31, 2022 | | |
December 31, 2021 | |
Computer Equipment | |
$ | 447,860 | | |
$ | 353,880 | |
Furniture and Fixtures | |
| 184,524 | | |
| 102,416 | |
Leasehold Improvements | |
| 47,616 | | |
| 11,457 | |
| |
| 680,000 | | |
| 467,753 | |
Less: Accumulated Depreciation | |
| (467,455 | ) | |
| (364,814 | ) |
| |
$ | 212,545 | | |
$ | 102,939 | |
Depreciation expense was $102,643 and $49,254 for the year ended December
31, 2022 and 2021, respectively.
Note 6 – Notes Payable
Notes payable as of December 31, 2022 and 2021
is as follows:
| |
Outstanding Principal as of | | |
| | |
|
| |
December 31, 2022 | | |
December 31, 2021 | | |
Interest Rate | | |
Maturity Date |
Seller’s Choice Note | |
$ | - | | |
$ | 660,000 | | |
| 30 | % | |
September 2020 |
The April 2020 PPP Loan Agreement | |
| 198,577 | | |
| 198,577 | | |
| 1 | % | |
May 2022 |
The First December 2021 Loan Agreement | |
| - | | |
| 185,655 | | |
| 10 | % | |
June 2023 |
The Second December 2021 Loan Agreement | |
| - | | |
| 313,979 | | |
| 14 | % | |
June 2022 |
First Denver Bodega LLC Loan | |
| 38,014 | | |
| - | | |
| 5 | % | |
March 2025 |
The Third May 2022 Loan Agreement | |
| 9,409 | | |
| - | | |
| - | % | |
November 2022 |
The Fourth May 2022 Loan Agreement | |
| 31,701 | | |
| - | | |
| - | % | |
November 2022 |
The Second June Loan agreement | |
| 39,500 | | |
| - | | |
| - | % | |
October 2022 |
The First August 2022 Loan Agreement | |
| 130,615 | | |
| - | | |
| 14 | % | |
November 2022 |
The Second August 2022 Loan Agreement | |
| 387,950 | | |
| - | | |
| - | % | |
January 2023 |
The First September 2022 Loan Agreement | |
| 73,236 | | |
| - | | |
| - | % | |
September 2023 |
The Second September 2022 Loan Agreement | |
| 763,625 | | |
| - | | |
| - | % | |
May 2023 |
The Third September 2022 Loan Agreement | |
| 256,964 | | |
| - | | |
| - | % | |
April 2023 |
The November 2022 Loan | |
| 68,211 | | |
| - | | |
| - | % | |
June 2023 |
| |
| 1,683,694 | | |
| 1,358,211 | | |
| | | |
|
Less: Debt Discount | |
| (314,108 | ) | |
| (15,547 | ) | |
| | | |
|
Less: Debt Issuance Costs | |
| - | | |
| - | | |
| | | |
|
| |
| 1,683,694 | | |
| 1,342,664 | | |
| | | |
|
Less: Current Debt | |
| (1,645,680 | ) | |
| (1,278,672 | ) | |
| | | |
|
Total Long-Term Debt | |
$ | 38,014 | | |
$ | 63,992 | | |
| | | |
|
Seller’s Choice Note
On September 11, 2019, the Company entered into
Seller’s Choice Purchase Agreement with Home Revolution LLC. As a part of the consideration provided pursuant to the Seller’s
Choice Acquisition, the Company issued the Seller’s Choice Note to the Seller in the principal amount of $660,000. The Seller’s
Choice Note bears interest at a rate of 9.5% per annum and is payable on March 11, 2020 (the “Seller’s Choice Maturity
Date”) at which time all outstanding principal, accrued and unpaid interest and other amounts become due. Upon maturity the
Company utilized an automatic extension up to 6 months. This resulted in a 5% increase in the interest rate every month the Seller’s
Choice Note is outstanding. As of December 31, 2021, the Company was in default on the Seller’s Choice note.
On March 3, 2022, after substantial motion practice,
Creatd successfully settled the dispute with Home Revolution, LLC for a total of $799,000, which includes $660,000 of note
principal and $139,000 of accrued interest. The matter has been dismissed. As part of the settlement the Company recorded a Gain
on extinguishment of debt of $147,256.
The April 2020 PPP Loan Agreement
On April 30, 2020, the Company was granted a
loan with a principal amount of $282,432 (the “Loan”), pursuant to the Paycheck Protection Program (the “PPP”)
under Division A, Title I of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), which was enacted
on March 27, 2020. The Loan, which was in the form of a Note dated April 30, 2020, matures on April 30, 2022, and bears interest
at a fixed rate of 1.00% per annum, payable monthly commencing on October 30, 2020. The Note may be prepaid by the Company at any
time prior to maturity without payment of any premium. Funds from the Loan may only be used to retain workers and maintain payroll or
make mortgage payments, lease payments and utility payments.
During the year ended December 31, 2021, the
Company accrued interest of $1,637.
During the year ended December 31, 2021, the
Company repaid $83,855 in principal.
During the year ended December 31, 2022, the
Company accrued interest of $10,850.
As of December 31, 2022, the Loan is in default,
and the lender may require immediate payment of all amounts owed under the Loan or file suit and obtain judgment.
Subsequent to December 31, 2022, the Company made
a repayment of $5,000 towards this note.
The May 2020 PPP Loan Agreement
On May 4, 2020, Jerrick Ventures, LLC (“Jerrick
Ventures”), the Company’s wholly-owned subsidiary, was granted a loan from PNC Bank, N.A. with a principal amount of $412,500,
pursuant to the Paycheck Protection Program (the “PPP”). The Loan, which was in the form of a Note dated May 4, 2020,
matures on May 4, 2022, and bears interest at a fixed rate of 1.00% per annum, payable monthly commencing on November 4, 2020. The
Note may be prepaid by Jerrick Ventures at any time prior to maturity without payment of any premium. Funds from the Loan may only be
used to retain workers and maintain payroll or make mortgage payments, lease payments and utility payments. Jerrick Ventures intends
to use the entire Loan amount for qualifying expenses. Under the terms of the PPP, certain amounts of the Loan may be forgiven if they
are used for qualifying expenses as described in the CARES Act.
During the year ended December 31, 2021, the
Company accrued interest of $396.
During the year ended December 31, 2021, the
Company repaid $136,597 in principal and was forgiven $275,903 of principal and $3,119 of accrued interest.
The October 2020 Loan Agreement
On October 6, 2020, the Company entered into
a secured loan agreement (the “October 2020 Loan Agreement”) with a lender (the “October 2020 Lender”), whereby
the October 2020 Lender issued the Company a secured promissory note of $74,300 AUD or $54,412 United States Dollars (the “October
2020 Note”). Pursuant to the October 2020 Loan Agreement, the October 2020 Note has an effective interest rate of 14%. The
maturity date of the October 2020 Note is September 30, 2021 (the “October 2020 Maturity Date”) at which time all outstanding
principal, accrued and unpaid interest and other amounts due under the October 2020 Loan Agreement are due. The loan is secured by the
Australian research & development credit.
During the year ended December 31, 2021, the
Company accrued $4,850 AUD in interest.
During the year ended December 31, 2021, the
Company’s repaid $111,683 in principal and $6,408 in interest from our R&D tax credit receivable.
The November 2020 Loan Agreement
On November 24, 2020, the Company entered
into a loan agreement (the “November 2020 Loan Agreement”) with a lender (the “November 2020 Lender”) whereby
the November 2020 Lender issued the Company a promissory note of $34,000 (the “November 2020 Note”). Pursuant to the
November 2020 Loan Agreement, the November 2020 Note has an effective interest rate of 14%. The maturity date of the November 2020
Note is May 25, 2021 (the “November 2020 Maturity Date”), at which time all outstanding principal, accrued and unpaid interest
and other amounts due under the November 2020 Note are due.
During the year ended December 31, 2020, the
Company repaid $10,284 in principal.
During the year ended December 31, 2021, the
Company repaid $23,716 in principal and $4,736 of accrued interest.
The February 2021 Loan Agreement
On February 24, 2021, the Company entered into
a secured loan agreement (the “February 2021 Loan Agreement”) with a lender (the “February 2021 Lender”), whereby
the February 2021 Lender issued the Company a secured promissory note of $111,683 AUD or $81,789 United States Dollars (the
“February 2021 Note”). Pursuant to the February 2021 Loan Agreement, the February 2021 Note has an effective interest rate
of 14%. The maturity date of the February 2021 Note is July 31, 2021 (the “February 2021 Maturity Date”) at which
time all outstanding principal, accrued and unpaid interest and other amounts due under the February 2021 Loan Agreement are due. The
loan is secured by the Australian research & development credit.
During the year ended December 31, 2021, the
Company accrued $9,339 AUD in interest.
The April 2021 Loan Agreement
On April 9, 2021, the Company entered into
a loan agreement (the “April 2021 Loan Agreement”) with a lender (the “April 2021 Lender”) whereby the April
2021 Lender issued the Company a promissory note of $128,110 (the “April 2021 Note”). Pursuant to the April 2021 Loan
Agreement, the April 2021 Note has an effective interest rate of 11%. The maturity date of the April 2021 Note is October 8,
2022 (the “April 2021 Maturity Date”), at which time all outstanding principal, accrued and unpaid interest and other amounts
due under the April 2021 Note are due.
During the year ended December 31, 2021, the
Company repaid $92,140 in principal and converted $35,970 into the July 2021 Loan Agreement. As part of the conversion the
Company recorded $8,341 as extinguishment expense.
The July 2021 Loan Agreement
On July 2, 2021, the Company entered into
a loan agreement (the “July 2021 Loan Agreement”) with a lender (the “July 2021 Lender”) whereby the July 2021
Lender issued the Company a promissory note of $137,625 (the “July 2021 Note”). Pursuant to the July 2021 Loan Agreement,
the July 2021 Note has an effective interest rate of 10%. The maturity date of the July 2021 Note is December 31, 2022 (the
“July 2021 Maturity Date”), at which time all outstanding principal, accrued and unpaid interest and other amounts due under
the July 2021 Note are due.
During the year ended December 31, 2021, the
Company repaid $113,606 in principal and converted $24,019 into the Second December 2021 Loan. As part of the conversion the
Company recorded $7,109 as extinguishment expense.
The First December 2021 Loan Agreement
On December 3, 2021, the Company entered
into a loan agreement (the “First December 2021 Loan Agreement”) with a lender (the “First December 2021 Lender”)
whereby the First December 2021 Lender issued the Company a promissory note of $191,975 (the “First December 2021 Note”).
Pursuant to the First December 2021 Loan Agreement, the First December 2021 Note has an effective interest rate of 9%. The
maturity date of the First December 2021 Note is June 3, 2023 (the “First December 2021 Maturity Date”), at which time all
outstanding principal, accrued and unpaid interest and other amounts due under the First December 2021 Note are due.
During the year ended December 31, 2021, the
Company repaid $6,320 in principal.
During the year ended December 31, 2022, the
Company repaid $185,655 in principal.
The Second December 2021 Loan Agreement
On December 14, 2021, the Company entered into
a secured loan agreement (the “Second December 2021 Loan Agreement”) with a lender (the “Second December 2021 Lender”),
whereby the Second December 2021 Lender issued the Company a secured promissory note of $438,096 AUD or $329,127 United States
Dollars (the “Second December 2021 Note”). Pursuant to the Second December 2021 Loan Agreement, the Second December 2021
Note has an effective interest rate of 14%. The maturity date of the Second December 2021 Note is June 30, 2022 (the
“Second December 2021 Maturity Date”) at which time all outstanding principal, accrued and unpaid interest and other amounts
due under the Second December 2021 Loan Agreement are due. The Company has the option to extend the Maturity date by 60 days. The loan
is secured by the Australian research & development credit.
During the year ended December 31, 2022, the
Company repaid $293,499 of principal and $26,115 of interest.
The First February 2022 Loan Agreement
On February 22, 2022, the Company entered into
a secured loan agreement (the “First February 2022 Loan Agreement”) with a lender (the “First February 2022 Lender”),
whereby the First February 2022 Lender issued the Company a secured promissory note of $222,540 AUD or $159,223 United States
Dollars (the “First February 2022 Note”). Pursuant to the First February 2022 Loan Agreement, the First February 2022 Note
has an effective interest rate of 14%. The maturity date of the First February 2022 Note is June 30, 2022 (the “First
February 2022 Maturity Date”) at which time all outstanding principal, accrued and unpaid interest and other amounts due under
the First February 2022 Loan Agreement are due. The Company has the option to extend the Maturity date by 60 days. The loan is secured
by the Australian research & development credit.
During the year ended December 31, 2022, the Company
repaid $159,223 of principal and $8,120 of interest.
Denver Bodega LLC Notes Payable
On March 7, 2022, The Company acquired five note
payable agreements from the acquisition of Denver Bodega LLC. See note 12. The total liabilities of these notes amounted to $293,888.
During the year ended December 31, 2022, the Company repaid $255,874. As of December 31, 2022, the Company has one note outstanding. This
note has a principal balance of $38,014, bears interest at 5%, and requires 36 monthly payments of $1,496.
Subsequent to December 31, 2022, the Company made payments totaling $5,994
towards this note.
The First May 2022 Loan Agreement
On May 9, 2022, the Company entered into a loan
agreement (the “First May 2022 Loan Agreement”) with a lender (the “First May 2022 Lender”), whereby the First
May 2022 Lender issued the Company a promissory note of $693,500 (the “First May 2022 Note”). The Company received cash
proceeds of $455,924. Pursuant to the First May 2022 Loan Agreement, the First May 2022 Note has an effective interest rate of 143%. The
maturity date of the First May 2022 Note is December 18, 2022 (the “First May 2022 Maturity Date”). The Company is required
to make weekly payment of $21,673. The First May 2022 Note is secured by officers of the Company.
The Company recorded a $237,576 debt discount
relating to an original issue discount. The debt discount is being accreted over the life of the note to accretion of debt discount and
issuance cost.
During the year ended December 31, 2022, the
Company repaid $390,114 in principal.
On September 22, 2022, the Company and the First
May 2022 Lender entered into an exchange agreement whereas both parties agreed to roll the remaining $303,386 in the Second September
2022 Loan Agreement. Since the PV cashflows of the new and old debt were more than 10% differences the company used extinguishment accounting.
As part of the agreement the Company recognized $33,079 as loss on extinguishment of debt due to the remaining debt discount on the First
May 2022 Loan Agreement.
The Second May 2022 Loan Agreement
On May 9, 2022, the Company entered into a loan
agreement (the “Second May 2022 Loan Agreement”) with a lender (the “Second May 2022 Lender”), whereby the Second
May 2022 Lender issued the Company a promissory note of $401,500 (the “Second May 2022 Note”). The Company received
cash proceeds of $263,815. Pursuant to the Second May 2022 Loan Agreement, the Second May 2022 Note has an effective interest rate of 162
%. The maturity date of the Second May 2022 Note is November 20, 2022 (the “Second May 2022 Maturity Date”). The
Company is required to make weekly payment of $14,339. The Second May 2022 Note is secured by officers of the Company.
The Company recorded a $137,685 debt discount
relating to an original issue discount. The debt discount is being accreted over the life of the note to accretion of debt discount and
issuance cost.
During the year ended December 31, 2022, the
Company repaid $272,447 in principal.
On September 23, 2022, the Company and the Second
May 2022 Lender entered into an exchange agreement whereas both parties agreed to roll the remaining $129,053 in the Third September
2022 Loan Agreement. Since the PV cashflows of the new and old debt were more than 10% differences the company used extinguishment accounting.
As part of the agreement the Company recognized $3,905 as loss on extinguishment of debt due to the remaining debt discount on the Second
May 2022 Loan Agreement.
The Third May 2022 Loan Agreement
On May 25, 2022, the Company entered into a loan
agreement (the “Third May 2022 Loan Agreement”) with a lender (the “Third May 2022 Lender”), whereby the Third
May 2022 Lender issued the Company a promissory note of $27,604 (the “Third May 2022 Note”). Pursuant to the Third May 2022
Loan Agreement, the Third May 2022 Note has an effective interest rate of 20%. The maturity date of the Third May 2022 Note
is November 23, 2022 (the “Third May 2022 Maturity Date”). The Company is required to make monthly payments of $3,067.
During the year ended December 31, 2022, the Company
repaid $18,195 in principal.
Subsequent to December 31, 2022, the Company made
repayments of $4,432 towards this note.
The Fourth May 2022 Loan Agreement
On May 26, 2022, the Company entered into a loan
agreement (the “Fourth May 2022 Loan Agreement”) with a lender (the “Fourth May 2022 Lender”), whereby the Fourth
May 2022 Lender issued the Company a promissory note of $45,200 (the “Fourth May 2022 Note”). Pursuant to the Fourth
May 2022 Loan Agreement, the Fourth May 2022 Note has an effective interest rate of 17%. The maturity date of the Fourth May
2022 Note is November 23, 2022 (the “Fourth May 2022 Maturity Date”).
During the year ended December 31, 2022, the
Company repaid $13,499 in principal.
Subsequent to December 31, 2022, the Company made
repayments of $7,097 towards this note.
The First June 2022 Loan Agreement
On June 17, 2022, the Company entered into a loan
agreement (the “First June 2022 Loan Agreement”) with a lender (the “First June 2022 Lender”), whereby the First
June 2022 Lender issued the Company a promissory note of $568,000 (the “First June 2022 Note”). The Company received
cash proceeds of $378,000. Pursuant to the First June 2022 Loan Agreement, the First June 2022 Note has an effective interest rate of 217%. The
maturity date of the First June 2022 Note is November 4, 2022 (the “First June 2022 Maturity Date”). The Company is required
to make weekly payment of $28,400. The First June 2022 Note is secured by officers of the Company.
The Company recorded a $190,000 debt discount
relating to an original issue discount. The debt discount is being accreted over the life of the note to accretion of debt discount and
issuance cost.
During the year ended December 31, 2022, the
Company repaid $255,600 in principal.
On August 19, 2022, the Company and the First
June 2022 Lender entered into an exchange agreement whereas both parties agreed to roll the remaining $312,400 in the Third September
2022 Loan Agreement. Since the PV cashflows of the new and old debt were more than 10% differences the company used extinguishment accounting.
As part of the agreement the Company recognized $66,749 as loss on extinguishment of debt due to the remaining debt discount on the Second
May 2022 Loan Agreement.
The Second June 2022 Loan Agreement
On June 17, 2022, the Company entered into a loan
agreement (the “Second June 2022 Loan Agreement”) with a lender (the “Second June 2022 Lender”), whereby the Second
June 2022 Lender issued the Company a promissory note of $104,500 (the “Second June 2022 Note”). The Note holder repaid
a vendor liability of $104,500. The maturity date of the Second June 2022 Note is October 15, 2022 (the “Second June 2022 Maturity
Date”).
The First August 2022 Loan Agreement
On August 18, 2022, the Company entered into a
secured loan agreement (the “First August 2022 Loan Agreement”) with a lender (the “First August 2022 Lender”),
whereby the First August 2022 Lender issued the Company a secured promissory note of $193,500 AUD or $134,070 United States Dollars
(the “First August 2022 Note”). Pursuant to the First August 2022 Loan Agreement, the First August 2022 Note has an effective
interest rate of 14%. The maturity date of the First August 2022 Note is June 30, 2023 (the “First August 2022 Maturity
Date”) at which time all outstanding principal, accrued and unpaid interest and other amounts due under the First August 2022 Loan
Agreement are due. The Company has the option to extend the Maturity date by 60 days. The loan is secured by the Australian research
& development credit.
During the year ended December 31, 2022, the
Company accrued $2,037 AUD in interest.
The Second August 2022 Loan Agreement
On August 19, 2022, the Company entered into a
loan agreement (the “Second August 2022 Loan Agreement”) with a lender (the “Second August 2022 Lender”), whereby
the Second August 2022 Lender issued the Company a promissory note of $923,000 (the “Second August 2022 Note”). The Company
received cash proceeds of $300,100 and rolled the remaining $312,400 of principal from the June 2022 Loan Agreement. Pursuant to the Second
August 2022 Loan Agreement, the Second August 2022 Note has an effective interest rate of 167%. The maturity date of the Second
August 2022 Note is January 9, 2022 (the “Second August 2022 Maturity Date”). The Company is required to make weekly payment
of $46,150. The Second August 2022 Note is secured by officers of the Company.
The Company recorded a $310,500 debt discount
relating to an original issue discount. The debt discount is being accreted over the life of the note to accretion of debt discount and
issuance cost.
During the year ended December 31, 2022, the
Company repaid $535,050 in principal.
Subsequent to December 31, 2022, the Company made
repayments of $312,000 towards this note.
The First September 2022 Loan Agreement
On September 1, 2022, the Company entered into
a loan agreement (the “First September 2022 Loan Agreement”) with a lender (the “First September 2022 Lender”),
whereby the First September 2022 Lender issued the Company a promissory note of $87,884 (the “First September 2022 Note”).
Pursuant to the First September 2022 Loan Agreement, the First September 2022 Note has an effective interest rate of 13%. The
maturity date of the First September 2022 Note is September 1, 2023 (the “First September 2022 Maturity Date”).
During the year ended December 31, 2022, the
Company repaid $14,647 in principal.
Subsequent to December 31, 2022, the Company made payments totaling $21,971
towards this note.
The Second September 2022 Loan Agreement
On September 22, 2022, the Company entered into
a loan agreement (the “Second September 2022 Loan Agreement”) with a lender (the “Second September 2022 Lender”),
whereby the Second September 2022 Lender issued the Company a promissory note of $876,000 (the “Second September 2022 Note”).
The Company received cash proceeds of $272,614 and rolled the remaining $303,386 of principal from the First May 2022 Loan Agreement.
Pursuant to the Second September 2022 Loan Agreement, the Second September 2022 Note has an effective interest rate of 100%. The
maturity date of the Second September 2022 Note is May 5, 2023 (the “Second September 2022 Maturity Date”). The Company is
required to make weekly payment of $27,375. The Second September 2022 Note is secured by officers of the Company.
The Company recorded a $300,000 debt discount
relating to an original issue discount. The debt discount is being accreted over the life of the note to accretion of debt discount and
issuance cost.
During the year ended December 31, 2022, the
Company repaid $112,375 in principal.
Subsequent to December 31, 2022, the Company made
repayments of $117,000 towards these notes.
The Third September 2022 Loan Agreement
On September 22, 2022, the Company entered into
a loan agreement (the “Third September 2022 Loan Agreement”) with a lender (the “Third September 2022 Lender”),
whereby the Third September 2022 Lender issued the Company a promissory note of $365,000 (the “Third September 2022 Note”).
The Company received cash proceeds of $110,762 and rolled the remaining $129,053 of principal from the Second May 2022 Loan Agreement.
Pursuant to the Third September 2022 Loan Agreement, the Third September 2022 Note has an effective interest rate of 143%. The
maturity date of the Third September 2022 Note is May 5, 2023 (the “Second September 2022 Maturity Date”). The Company is
required to make weekly payment of $13,036. The Third September 2022 Note is secured by officers of the Company.
The Company recorded a $300,000 debt discount
relating to an original issue discount. The debt discount is being accreted over the life of the note to accretion of debt discount and
issuance cost.
During the year ended December 31, 2022, the
Company repaid $108,036 in principal.
Subsequent to December 31, 2022, the Company made
repayments of $140,000 towards this note.
The November 2022 Loan Agreement
On November 15, 2022, the Company entered
into a loan agreement (the “November 2022 Loan Agreement”) with a lender (the “November 2022 Lender”) whereby
the November 2022 Lender issued the Company a promissory note of $80,325 (the “November 2022 Note”). Pursuant to the
November 2022 Loan Agreement, the November 2022 Note has an effective interest rate of 21%. The maturity date of the November
2022 Note is June 3, 2023 (the “November 2022 Maturity Date”), at which time all outstanding principal, accrued and
unpaid interest and other amounts due under the November 2022 Note are due.
During the year ended December 31, 2022, the
Company repaid $12,114 in principal.
Subsequent to December 31, 2022, the Company made
repayments of $36,468 towards this note.
Note 7 – Convertible Notes Payable
Convertible notes payable as of December 31, 2022, is as follows:
| |
Outstanding Principal as of December 31,
| | |
Outstanding Principal as of December 31,
| | |
Interest | | |
Conversion | | |
|
Maturity | |
Warrants granted | |
| |
2022 | | |
2021 | | |
Rate | | |
Price | | |
|
Date | |
Quantity | | |
Exercise Price | |
The July 2021 Convertible Loan Agreement | |
| - | | |
| 168,850 | | |
| 6.0 | % | |
| - | (*) | |
|
July -22 | |
| - | | |
| - | |
The May 2022 Convertible Loan Agreement | |
| 50,092 | | |
| - | | |
| 11 | % | |
| - | (*) | |
|
May-23 | |
| - | | |
| - | |
The May 2022 Convertible Note Offering | |
| 990,000 | | |
| - | | |
| 18 | % | |
| 2.00 | (*) | |
|
November-22 | |
| 4,000,000 | | |
| $3.00 – $6.00 | |
The July 2022 Convertible Note Offering | |
| 3,750,000 | | |
| - | | |
| 18 | % | |
| 0.20 | (*) | |
|
March-23 | |
| 2,150,000 | | |
| $3.00 – $6.00 | |
The First October 2022 Convertible Loan Agreement | |
| 104,250 | | |
| - | | |
| 10 | % | |
| - | (*) | |
|
September-23 | |
| | | |
| | |
The Second October 2022 Convertible Loan Agreement | |
| 300,000 | | |
| - | | |
| 10 | % | |
| - | (*) | |
|
October-23 | |
| | | |
| | |
The Third October 2022 Convertible Loan Agreement | |
| 866,650 | | |
| - | | |
| 10 | % | |
| 0.20 | (*) | |
|
April-23 | |
| | | |
| | |
The December 2022 Convertible Loan Agreement | |
| 750,000 | | |
| - | | |
| - | % | |
| 0.20 | (*) | |
|
April-23 | |
| 562,500.00 | | |
$ | 0.20 | |
| |
| 6,810,992 | | |
| 168,850 | | |
| | | |
| | | |
|
| |
| | | |
| | |
Less: Debt Discount | |
| (1,426,728 | ) | |
| (8,120 | ) | |
| | | |
| | | |
|
| |
| | | |
| | |
Less: Debt Issuance Costs | |
| (14,665 | ) | |
| (1,537 | ) | |
| | | |
| | | |
|
| |
| | | |
| | |
| |
| 5,369,599 | | |
| 159,193 | | |
| | | |
| | | |
|
| |
| | | |
| | |
(*) | As subject to adjustment as further outlined in the notes |
The First July 2020 Convertible Loan Agreement
On July 1, 2020, the Company entered into a loan
agreement (the “First July 2020 Loan Agreement”) with an individual (the “First July 2020 Lender”), whereby the
First July 2020 Lender issued the Company a promissory note of $68,000 (the “First July 2020 Note”). Pursuant to the
First July 2020 Loan Agreement, the First July 2020 Note has interest of ten percent (10%). The First July 2020 Note matures on June 29,
2021.
Upon default or 180 days after issuance the First
July 2020 Note is convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”)
equal to 61% multiplied by the lowest trade of the common stock during the twenty (15) consecutive trading day period immediately preceding
the date of the respective conversion.
During the year ended December 31, 2021, the
First July 2020 Note became convertible. Due to the fact that these convertible notes have an option to convert at a variable amount,
they are subject to derivative liability treatment. The Company has applied ASC 815, due to the potential for settlement in a variable
quantity of shares. The conversion feature has been measured at fair value using a Binomial model at the conversion date and the period
end. The conversion feature of First July 2020 Note gave rise to a derivative liability of $112,743. The Company recorded $68,000 as
a debt discount and $44,743 was recorded to derivative expense. The debt discount is charged to accretion of debt discount over
the remaining term of the convertible note.
During the year ended December 31, 2021, the
Company converted $68,000 in principal and $3,400 in interest into 35,469 shares of the Company’s common stock.
The September 2020 Convertible Loan Agreement
On September 23, 2020, the Company entered into
a loan agreement (the “September 2020 Loan Agreement”) with an individual (the “September 2020 Lender”), whereby
the September 2020 Lender issued the Company a promissory note of $385,000 (the “September 2020 Note”). Pursuant to
the September 2020 Loan Agreement, the September 2020 Note has interest of twelve percent (12%). The September 2020 Note matures on September
23, 2021.
Upon default or 180 days after issuance the Second
July 2020 Note is convertible into shares of the Company’s common stock, par value $.001 per share equal to the closing bid price
of the Company’s common stock on the trading day immediately preceding the date of the respective conversion.
The Company recorded a $68,255 debt discount
relating to original issue discount associated with this note. The Company recorded a $146,393 debt discount relating to 85,555 warrants
issued to investors based on the relative fair value of each equity instrument on the dates of issuance. The debt discount is being accreted
over the life of the note to accretion of debt discount and issuance cost.
During the year ended December 31, 2021, the
Company repaid $341,880 in principal and $46,200 in interest.
The October 2020 Convertible Loan Agreement
On October 2, 2020, the Company entered into
a loan agreement (the “October 2020 Loan Agreement”) with an individual (the “October 2020 Lender”), whereby
the October 2020 Lender issued the Company a promissory note of $169,400 (the “October 2020 Note”). Pursuant to the
October 2020 Loan Agreement, the October 2020 Note has interest of six percent (6%). The October 2020 Note matures on the first (12th)
month anniversary of its issuance date.
Upon default or 180 days after issuance the October
2020 Note is convertible into shares of the Company’s common stock, par value $0.001 per share (“Conversion Shares”)
equal to 75% of average the lowest three trading prices of the Company’s common stock on the fifteen-trading day immediately
preceding the date of the respective conversion.
The Company recorded a $19,400 debt discount
relating to original issue discount associated with this note. The debt discount is being accreted over the life of the note to accretion
of debt discount and issuance cost.
During the year ended December 31, 2021, the
Second July 2020 Note became convertible. Due to the fact that these convertible notes have an option to convert at a variable amount,
they are subject to derivative liability treatment. The Company has applied ASC 815, due to the potential for settlement in a variable
quantity of shares. The conversion feature has been measured at fair value using a Binomial model at the conversion date and the period
end. The conversion feature of Second July 2020 Note gave rise to a derivative liability of $74,860. The Company recorded this as a debt
discount. The debt discount is charged to accretion of debt discount over the remaining term of the convertible note.
During the year ended December 31, 2021, the
Company converted $169,400 in principal and $4,620 in interest into 55,631 shares of the Company’s common stock.
The First December 2020 convertible Loan
Agreement
On December 9, 2020, the Company entered into
a loan agreement (the “First December 2020 Loan Agreement”) with an individual (the “First December 2020 Lender”),
whereby the First December 2020 Lender issued the Company a promissory note of $600,000 (the “First December 2020 Note”).
Pursuant to the First December 2020 Loan Agreement, the First December 2020 Note has interest of twelve percent (12%). As additional
consideration for entering in the First December 2020 convertible Loan Agreement, the Company issued 45,000 shares of the Company’s
common stock. The First December 2020 Note matures on the first (12th) month anniversary of its issuance date.
Upon default the First December 2020 Note is
convertible into shares of the Company’s common stock, par value $.001 per share (“Conversion Shares”) equal to the
closing bid price of the Company’s common stock on the trading day immediately preceding the date of the respective conversion.
The Company recorded a $110,300 debt discount
relating to original issue discount associated with this note. The Company recorded a $113,481 debt discount relating to 45,000 shares
issued to investors based on the relative fair value of each equity instrument on the dates of issuance. The debt discount is being accreted
over the life of the note to accretion of debt discount and issuance cost.
During the year ended December 31, 2021, the
Company repaid $600,000 in principal and $4,340 in interest.
The May 2021 Convertible Note Offering
On May 14, 2021, the Company conducted multiple
closings of a private placement offering to accredited investors (the “May 2021 Convertible Note Offering”) of units of the
Company’s securities by entering into subscription agreements with “accredited investors” (the “May 2021 Investors”)
for aggregate gross proceeds of $3,690,491. The May 2021 convertible notes are convertible into shares of the Company’s common
stock, par value $.001 per share at a conversion price of $5.00 per share. As additional consideration for entering in the
May 2021 Convertible Note Offering, the Company issued 1,090,908 warrants of the Company’s common stock. The May
2021 Convertible Note matures on November 14, 2022.
The Company recorded a $1,601,452 debt discount
relating to 1,090,908 warrants issued to investors based on the relative fair value of each equity instrument on the dates
of issuance. The debt discount is being accreted over the life of these notes to accretion of debt discount and issuance cost.
The Company recorded a $666,669 debt discount
relating to an original issue discount and $539,509 of debt issuance costs related to fees paid to vendors relating to the offering.
The debt discount and debt issuance costs are being accreted over the life of the note to accretion of debt discount and issuance cost.
During the year ended December 31, 2021, the Company converted $4,666,669 in
principal into 933,334 shares of the Company’s common stock.
The July 2021 Convertible Loan Agreement
On July 6, 2021, the Company entered into a loan
agreement (the “July 2021 Loan Agreement”) with an individual (the “July 2021 Lender”), whereby the July 2021
Lender issued the Company a promissory note of $168,850 (the “July 2021 Note”). Pursuant to the July 2021 Loan Agreement,
the July 2021 Note has interest of six percent (6%). The July 2021 Note matures on the first (12th) month anniversary of its
issuance date.
Upon default or 180 days after issuance the July
2021 Note is convertible into shares of the Company’s common stock, par value $0.001 per share (“Conversion Shares”)
equal to 75% of average the lowest three trading prices of the Company’s common stock on the fifteen-trading day immediately
preceding the date of the respective conversion.
The Company recorded a $15,850 debt discount
relating to an original issue discount and $3,000 of debt issuance costs related to fees paid to vendors relating to the offering.
The debt discount and debt issuance costs are being accreted over the life of the note to accretion of debt discount and issuance cost.
During the year ended December 31, 2022, the
July 2021 Note became convertible. Due to the fact that these convertible notes have an option to convert at a variable amount, they
are subject to derivative liability treatment. The Company has applied ASC 815, due to the potential for settlement in a variable quantity
of shares. The conversion feature has been measured at fair value using a Binomial model at the conversion date. The conversion feature
of July 2021 Note gave rise to a derivative liability of $100,532. The Company recorded this as a debt discount. The debt discount is
charged to accretion of debt discount over the remaining term of the convertible note.
During the year ended December 31, 2022, the
note holder converted $168,850 of principal and $4,605 of interest into 109,435 shares of the Company’s common
stock. The unamortized debt discount of $96,803 was recorded to extinguishment of debt due to conversion.
The Second February 2022 Loan Agreement
On February 22, 2022, the Company entered into
a loan agreement (the “Second February 2022 Loan Agreement”) with a lender (the “Second February 2022 Lender”),
whereby the Second February 2022 Lender issued the Company a promissory note of $337,163 (the “Second February 2022 Note”).
Pursuant to the Second February 2022 Loan Agreement, the Second February 2022 Note has an interest rate of 11%. The maturity
date of the Second February 2022 Note is February 22, 2023 (the “Second February 2022 Maturity Date”). The Company is required
to make 10 monthly payments of $37,425.
Upon default the Second February 2022 Note is
convertible into shares of the Company’s common stock, par value $0.001 per share (“Conversion Shares”) equal
to 75% of average the lowest three trading prices of the Company’s common stock on the ten-trading day immediately preceding
the date of the respective conversion.
The Company recorded a $37,163 debt discount
relating to an original issue discount. The debt discount is being accreted over the life of the note to accretion of debt discount and
issuance cost.
During the year ended December 31, 2022, the
Company repaid $299,400 in principal and converted $74,850 in principal into 216,842 shares of the Company’s common stock.
The May 2022 Convertible Loan Agreement
On May 20, 2022, the Company entered into a loan
agreement (the “May 2022 Loan Agreement”) with an individual (the “May 2022 Lender”), whereby the May 2022 Lender
issued the Company a promissory note of $115,163 (the “May 2022 Note”). Pursuant to the May 2022 Loan Agreement, the
May 2022 Note has an interest rate of 11%. The May 2022 Note matures on the first (12th) month anniversary of its issuance
date.
Upon default the May 2022 Note is convertible
into shares of the Company’s common stock, par value $0.001 per share (“Conversion Shares”) equal to 75%
of average the lowest three trading prices of the Company’s common stock on the ten-trading day immediately preceding the date
of the respective conversion.
The Company recorded a $15,163 debt discount
relating to an original issue discount The debt discount and debt issuance costs are being accreted over the life of the note to accretion
of debt discount and issuance cost.
During the year ended December 31, 2022, the
Company repaid $63,915 in principal and converted $12,783 in principal into 39,637 shares of the Company’s common stock.
Subsequent to December 31, 2022, the May 2022
Lender converted $51,132 in principal into shares of the Company’s common stock and repaid the remaining note balance.
The May 2022 Convertible Note Offering
During May of 2022, the Company conducted multiple
closings of a private placement offering to accredited investors (the “May 2022 Convertible Note Offering”) of units of the
Company’s securities by entering into subscription agreements with “accredited investors” (the “May 2022 Investors”)
for aggregate gross proceeds of $4,000,000. The May 2022 convertible notes are convertible into shares of the Company’s common
stock, par value $.001 per share at a conversion price of $2.00 per share. As additional consideration for entering in the
May 2022 Convertible Note Offering, the Company issued 4,000,000 warrants of the Company’s common stock. The May 2022
Convertible Note matures on November 30, 2022.
The Company recorded a $1,895,391 debt discount
relating to 4,000,000 warrants issued to investors based on the relative fair value of each equity instrument on the dates
of issuance. The debt discount is being accreted over the life of these notes to accretion of debt discount and issuance cost.
The Company recorded a $399,964 debt discount
relating to an original issue discount and $125,300 of debt issuance costs related to fees paid to vendors relating to the offering.
The debt discount and debt issuance costs are being accreted over the life of the note to accretion of debt discount and issuance cost.
On September 2, 2022, the Company went into default
on these notes. As part of the default terms the Company owes 110% of the principal outstanding and the notes accrue interest at a rate
of 18%.
On September 15, 2022, the Company and six out
of eight lenders May 2022 Investors agreed to forgive default interest and extend the maturity date to March 31, 2023, for a reduced conversion
price of $0.20 for the convertible notes and warrants. Since the PV cashflows of the new and old debt were more than 10% differences the
company used extinguishment accounting. As part of the agreement the Company recognized $1,083,684 as loss on extinguishment of debt due
to the remaining debt discount and recognized $331,861 as a gain on extinguishment of debt due to the forgiveness of interest. The company
also recognized an additional $75,610 of debt discount from the change in relative fair value on the warrants.
During the year ended December 31, 2022 the Company
repaid $1,314,286 in principal.
During the year ended December 31, 2022, the
Company accrued $75,674 in interest that was not forgiven. As of December 31, 2022, the Company is in default on $900,000 of principal
and $75,674 of interest.
Subsequent to December 31, 2022, the Company made
repayments totaling $785,714 towards these notes.
The July 2022 Convertible Note Offering
During July of 2022, the Company conducted multiple
closings of a private placement offering to accredited investors (the “July 2022 Convertible Note Offering”) of units of
the Company’s securities by entering into subscription agreements with “accredited investors” (the “July 2022
Investors”) for aggregate gross proceeds of $2,150,000. The July 2022 convertible notes are convertible into shares of the Company’s
common stock, par value $.001 per share at a conversion price of $2.00 per share. As additional consideration for entering
in the July 2022 Convertible Note Offering, the Company issued 2,150,000 warrants of the Company’s common stock. The
July 2022 Convertible Note matures on November 30, 2022.
The Company recorded a $863,792 debt discount
relating to 2,150,000 warrants issued to investors based on the relative fair value of each equity instrument on the dates
of issuance. The debt discount is being accreted over the life of these notes to accretion of debt discount and issuance cost.
The Company recorded a $214,981 debt discount
relating to an original issue discount. The debt discount are being accreted over the life of the note to accretion of debt discount
and issuance cost.
On September 2, 2022, the Company went into default
on these notes. As part of the default terms the Company owes 110% of the principal outstanding and the notes accrue interest at a rate
of 18%.
On September 15, 2022, the Company and the July
Investors agreed to forgive default interest and extend the maturity date to March 31, 2023, for a reduced conversion price of $0.20 for
the convertible notes and warrants. Since the present value of the cash flows of the new and old debt were more than 10% different, the
company used extinguishment accounting. As part of the agreement the Company recognized $339,594 as loss on extinguishment of debt due
to the remaining debt discount and recognized $230,162 as a gain on extinguishment of debt due to the forgiveness of interest.
During the year ended December 31, 2022, the Company
repaid $185,714 in principal.
Subsequent to December 31, 2022, the Company made
repayments totaling $714,286 towards these notes.
The First October 2022 Loan Agreement
On October 3, 2022, the Company entered into
a loan agreement (the “First October 2022 Loan Agreement”) with a lender (the “First October 2022 Lender”), whereby
the First October 2022 Lender issued the Company a promissory note of $104,250 (the “First October 2022 Note”). Pursuant
to the First October 2022 Loan Agreement, the First October 2022 Note has an interest rate of 10%. The maturity date of the
First October 2022 Note is September 29, 2023 (the “First October 2022 Maturity Date”).
On April 1, 2023, the First October 2022 Note
is convertible into shares of the Company’s common stock, par value $0.001 per share (“Conversion Shares”) equal
to 75% of average the lowest three trading prices of the Company’s common stock on the ten-trading day immediately preceding
the date of the respective conversion.
The Company recorded a $4,250 debt discount relating
to an original issue discount. The debt discount is being accreted over the life of the note to accretion of debt discount and issuance
cost.
The Second October 2022 Loan Agreement
On October 20, 2022, the Company entered into
a loan agreement (the “Second October 2022 Loan Agreement”) with a lender (the “Second October 2022 Lender”),
whereby the Second October 2022 Lender issued the Company a promissory note of $300,000 (the “Second October 2022 Note”).
Pursuant to the Second October 2022 Loan Agreement, the Second October 2022 Note has an interest rate of 10%. The maturity
date of the Second October 2022 Note is October 20, 2023 (the “Second October 2022 Maturity Date”).
Upon default, the Second October 2022 Note is
convertible into shares of the Company’s common stock, par value $0.001 per share (“Conversion Shares”) equal to the
lowest VWAP of the Company’s common stock on the twenty-trading day immediately preceding the date of the respective conversion.
The Company recorded a $45,000 debt discount
relating to an original issue discount, $409,945 relating to the fair value of 815,000 shares of common stock issue to the lender, and
$17,850 of debt issuance costs related to fees paid to vendors relating to the debt agreement. The debt discount and debt issuance cost
are being accreted over the life of the note to accretion of debt discount and issuance cost.
Subsequent to December 31, 2022, the Company
made a repayment of $47,143 towards the balance of the Second October 2022 Note.
The Third October 2022 Loan Agreement
On October 24, 2022, the Company entered into
a loan agreement (the “Third October 2022 Loan Agreement”) with a lender (the “Third October 2022 Lender”), whereby
the Third October 2022 Lender issued the Company a promissory note of $1,666,650 (the “Third October 2022 Note”). Pursuant
to the Third October 2022 Loan Agreement. The maturity date of the Third October 2022 Note is April 24, 2023 (the “Third October
2022 Maturity Date”).
The Third October 2022 Note is convertible into
shares of the Company’s common stock, par value $0.001 per share (“Conversion Shares”) equal to $0.20.
The Company recorded a $1,833,300 debt discount
relating to a $166,650 original issue discount and $1,666,650 from a beneficial conversion feature. The debt discount and debt issuance
cost are being accreted over the life of the note to accretion of debt discount and issuance cost.
During the year ended December 31, 2022, the
lender converted $800,000 into 4,000,000 shares of the Company’s common stock.
Subsequent to December 31, 2022, the Third October
2022 Lender converted the remaining balance of $866,650 into 4,333,250 shares of the Company’s common stock.
The December 2022 Loan Agreement
On December 12, 2022, the Company entered into
a loan agreement (the “December 2022 Loan Agreement”) with a lender (the “December 2022 Lender”), whereby the
December 2022 Lender issued the Company a promissory note of $750,000 (the “December 2022 Note”). Pursuant to the December
2022 Loan Agreement. The maturity date of the Third October 2022 Note is April 24, 2023 (the “Third October 2022 Maturity
Date”).
The Second October 2022 Note is convertible into
shares of the Company’s common stock, par value $0.001 per share (“Conversion Shares”) equal to $0.20.
The Company recorded a $241,773 debt discount
relating to 562,500 warrants issued to investors based on the relative fair value of each equity instrument on the dates of issuance
and $508,227 relating to the beneficial conversion feature. The debt discount is being accreted over the life of these notes to accretion
of debt discount and issuance cost.
Subsequent to December 31, 2022, the December
2022 Lender converted $500,000 into 2,500,000 shares of the Company’s common stock.
Note 8 – Related Party
Notes payable
The September 2020 Goldberg Loan Agreement
On September 15, 2020, the Company entered into
a loan agreement (the “September 2020 Goldberg Loan Agreement”) with Goldberg whereby the Company issued a promissory note
of $16,705 (the “September 2020 Goldberg Note”). Pursuant to the September 2020 Goldberg Loan Agreement, the September
2020 Goldberg Note has an interest rate of 7%. The maturity date of the September 2020 Goldberg Note is September 15, 2022
(the “September 2020 Goldberg Maturity Date”), at which time all outstanding principal, accrued and unpaid interest and other
amounts due under note are due. The September 2020 Goldberg Loan is secured by the tangible and intangible property of the Company.
Since the September 2020 Goldberg Note has a
make-whole provision if the shares of the Company’s common stock issued to the lender in accordance with the Lender’s
Exchange Agreement (see note 10) have a value equal to or less than $6,463,363 determined by using the lowest VWAP of the last 30 days
prior to September 14, 2021. The principal amount of the September 2020 Goldberg Note shall increase by 200% of the difference between
the initial consideration and the September 14, 2021, value. The Company has applied ASC 815, due to the potential for settlement
in a variable quantity of shares. The make-whole feature gave rise to a derivative liability that has been marked to market during the
year ended December 31, 2021, and the change in derivative liability is recorded on Consolidated Statements of Comprehensive Loss.
On September 15, 2021, the make-whole provision
was triggered, causing an increase in principal of the September 2020 Goldberg Note by $939,022.
During the year ended December 31, 2021, the
Company accrued interest of $3,576.
During the year ended December 31, 2021, the
Company entered into a settlement agreement whereas the Company agreed to pay $200,000 in cash and $150,000 in shares of Common
Stock.
The September 2020 Rosen Loan Agreement
On September 15, 2020, the Company entered into
a loan agreement (the “September 2020 Rosen Loan Agreement”) with Rosen whereby the Company issued a promissory note of $3,295 (the
“September 2020 Rosen Note”). Pursuant to the September 2020 Rosen Loan Agreement, the September 2020 Rosen Note has an interest
rate of 7%. The maturity date of the September 2020 Rosen Note is September 15, 2022 (the “September 2020 Rosen Maturity Date”),
at which time all outstanding principal, accrued and unpaid interest and other amounts due under the note are due. The September 2020
Rosen Loan is secured by the tangible and intangible property of the Company.
Since the September 2020 Rosen Note has a make-whole
provision if the shares of the Company’s common stock issued to the lender in accordance with the Lender’s Exchange
Agreement (see note 10) have a value equal to or less than $1,274,553 determined by using the lowest VWAP of the last 30 days prior to
September 14, 2021. The principal amount of the September 2020 Rosen Note shall increase by 200% of the difference the initial consideration
and the September 14, 2021 value. The Company has applied ASC 815, due to the potential for settlement in a variable quantity of
shares. The make-whole feature of gave rise to a derivative that has been marked to market during the year ended December 31, 2021, and
the change in derivative liability is recorded on Consolidated Statements of Comprehensive Loss.
On September 15, 2021 the make-whole provision
was triggered, causing an increase in principal of the September 2020 Rosen Note by $185,279.
During the year ended December 31, 2021, the
Company accrued interest of $1,610.
During the year ended December 31, 2021, the
Company repaid $188,574 in principal and $1,677 in interest.
Revenue
During the year ended December 31, 2021 the Company
received revenue of $80,000 from Dune for branded content services prior to consolidation but after recognition as an equity method
investee.
Equity raises
During the year ended December 31, 2022, the Company
conducted two equity raises in which officers, directors, employees, and an affiliate of an officer cumulatively invested $484,753 for 277,000
shares of common stock and 272,000 warrants to purchase common stock.
Officer compensation
During the year ended December 31, 2022 and 2021,
the Company paid $172,091 and $138,713, respectively for living expenses for officers of the Company.
Note 9 – Derivative Liabilities
The Company has identified derivative instruments
arising from convertible notes that have an option to convert at a variable number of shares in the Company’s convertible notes
payable during the year ended December 31, 2022 and 2021. For the terms of the conversion features see Note 7. The Company had no derivative
assets measured at fair value on a recurring basis as of December 31, 2022 or 2021.
The Company utilizes either a Monte Carlo simulation
model or a binomial option model for convertible notes that have an option to convert at a variable number of shares to compute the fair
value of the derivative and to mark to market the fair value of the derivative at each balance sheet date. The inputs utilized in the
application of the Binomial model included a stock price on valuation date, an expected term of each debenture remaining from the valuation
date to maturity, an estimated volatility, and a risk-free rate. The Company records the change in the fair value of the derivative as
other income or expense in the consolidated statements of operations.
Risk-free interest rate: The Company uses the
risk-free interest rate of a U.S. Treasury Note adjusted to be on a continuous return basis to align with the Monte Carlo simulation
model and binomial model.
Dividend yield: The Company uses a 0% expected
dividend yield as the Company has not paid dividends to date and does not anticipate declaring dividends in the near future.
Volatility: The Company calculates the expected
volatility based on the company’s historical stock prices with a look back period commensurate with the period to maturity.
Expected term: The Company’s remaining
term is based on the remaining contractual maturity of the convertible notes.
The following are the changes in the derivative
liabilities during the years ended December 31, 2022 and 2021.
| |
Years Ended
December 31, 2022 and 2021 | |
| |
Level 1 | | |
Level 2 | | |
Level 3 | |
Derivative liabilities as January 1, 2021 | |
$ | - | | |
$ | - | | |
$ | 42,231 | |
Addition | |
| - | | |
| - | | |
| 417,24 | |
Extinguishment | |
| - | | |
| - | | |
| (431,458 | ) |
Conversion to Note payable - related party | |
| - | | |
| - | | |
| (1,124,301 | ) |
Changes in fair value | |
| - | | |
| - | | |
| 1,096,287 | |
Derivative liabilities as December 31, 2021 | |
| - | | |
| - | | |
| - | |
Addition | |
| - | | |
| - | | |
| 100,532 | |
Changes in fair value | |
| - | | |
| - | | |
| (3,729 | ) |
Extinguishment | |
| - | | |
| - | | |
| (96,803 | ) |
Derivative liabilities as December 31, 2022 | |
$ | - | | |
$ | - | | |
$ | - | |
Note 10 – Stockholders’ Equity
Shares Authorized
The Company is authorized to issue up to one billion,
five hundred and twenty million (1,520,000,000) shares of capital stock, of which one billion five hundred million (1,500,000,000) shares
are designated as common stock, par value $0.001 per share, and twenty million (20,000,000) are designated as preferred stock, par
value $0.001 per share.
Preferred Stock
Series E Convertible Preferred Stock
The Company has designated 8,000 shares
of Series E Convertible Preferred stock and has 450 shares issued and outstanding as of December 31, 2022.
The shares of Series E Preferred Stock have a
stated value of $1,000 per share and are convertible into Common Stock at the election of the holder of the Series E Preferred Stock,
at any time following the Original Issue Date at a price of $4.12 per share, subject to adjustment. Each holder of Series E Preferred
Stock shall be entitled to receive, with respect to each share of Series E Preferred Stock then outstanding and held by such holder,
dividends on an as-converted basis in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends
are paid on shares of the Common Stock.
The holders of Series E Preferred Stock shall
be paid pari passu with the holders of Common Stock with respect to payment of dividends and rights upon liquidation and shall have no
voting rights. In addition, as further described in the Series E Designation, as long as any of the shares of Series E Preferred Stock
are outstanding, the Company shall not, without the affirmative vote of the holders of a majority of the then outstanding shares of Series
E Preferred Stock, (a) alter or change adversely the powers, preferences or rights given to the Series E Preferred Stock or alter or
amend this Series E Designation, (b) amend its certificate of incorporation or other charter documents in any manner that adversely affects
any rights of the holders of the Series E Preferred Stock, (c) increase the number of authorized shares of Series E Preferred Stock,
or (d) enter into any agreement with respect to any of the foregoing.
Each share of Series E Preferred Stock shall
be convertible, at any time and from time to time at the option of the holder of such shares, into that number of shares of Common Stock
determined by dividing the Series E Stated Value by the Conversion Price, subject to certain beneficial ownership limitations.
During the year ended December 31, 2021, the
Company received the $40,000 of the subscription receivable for the Series E Convertible Preferred Stock. The Company has recorded
$4,225 to stock issuance costs, which are part of Additional Paid-in Capital.
During the year ended December 31, 2021, investors
converted 7,278 shares of the Company’s Series E Convertible Preferred Stock into 1,766,449 shares of the Company’s
common stock.
During the year ended December 31, 2022, investors
converted 50 shares of the Company’s Series E Convertible Preferred Stock into 12,136 shares of the Company’s
common stock.
Common Stock
On January 14, 2021, the Company issued 30,000 shares
of its restricted common stock to consultants in exchange for services at a fair value of $133,200.
On January 20, 2021, the Company issued 40,000 shares
of its restricted common stock to consultants in exchange for a year of services at a fair value of $192,000. On May 24, 2021, the
Company amended the contract and issued and additional 10,000 shares of its restricted common stock. these shares had a fair
value of $34,500. The shares issued to the consultant were recorded as common stock issued for prepaid services and will be expensed
over the life of the consulting contract to share based payments. During the year ended December 31, 2021, the Company recorded $99,908 to
stock-based compensation expense related to these shares.
On February 1, 2021, the Company issued 50,000 shares
of its restricted common stock to consultants in exchange for services at a fair value of $196,000.
On February 3, 2021, the Company issued 1,929 shares
of its restricted common stock to consultants in exchange for services at a fair value of $8,198.
On February 8, 2021, the Company entered into
a consulting agreement whereas the Company issued a total of 2,092 shares of common stock in exchange for services at a fair
value of $7,502.
On February 18, 2021, the Company issued 10,000 shares
of its restricted common stock to consultants in exchange for services at a fair value of $48,000.
On February 18, 2021, the Company issued 10,417 shares
of its restricted common stock to consultants in exchange for services at a fair value of $50,002.
On February 26, 2021, the Company issued 291 shares
of its restricted common stock to consultants in exchange for services at a fair value of $1,499.
On March 17, 2021, the Company issued 9,624 shares
of its restricted common stock to consultants in exchange for services at a fair value of $49,371.
On March 28, 2021, the Company issued 31,782 shares
of its restricted common stock to settle outstanding vendor liabilities of $125,000.
On March 31, 2021, the Company issued 13,113 shares
of its restricted common stock to settle outstanding vendor liabilities of $43,667. In connection with this transaction the Company also
recorded a loss on settlement of vendor liabilities of $12,719.
On April 10, 2021, the Company issued 16,275 shares
of its restricted common stock to consultants in exchange for services at a fair value of $69,332.
On April 21, 2021, the Company entered into a
consulting agreement whereas the Company issued a total of 1,048 shares of common stock in exchange for services at a fair
value of $3,587.
On June 17, 2021, the Company entered into an
underwriting agreement with The Benchmark Company LLC, pursuant to which we agreed to sell to the Underwriter in a firm commitment underwritten
public offering an aggregate of 750,000 shares of the Company’s common stock, at a public offering price of $3.40 per
share. The Company also granted the Underwriter a 30-day option to purchase up to an additional 112,500 shares of Common
Stock to cover over-allotments, if any. The Offering closed on June 21, 2021. The net proceeds to the Company from the equity raise was
$2,213,500. As part of the underwriting agreement the Company issued 46,667 warrants of the Company’s common stock to
Benchmark. The warrants have an exercise price $5.40 and a term of five years. On July 9, 2021, the Representative exercised the
over-allotment option to purchase an additional 954,568 shares of Common Stock.
On July 20, 2021, the Company issued 2,154 shares
of its restricted common stock to consultants in exchange for services at a fair value of $8,570.
On July 15, 2021, the Company issued 715 shares
of its restricted common stock to consultants in exchange for services at a fair value of $2,500.
On August 15, 2021, the Company issued 820 shares
of its restricted common stock to consultants in exchange for services at a fair value of $2,500.
On August 26, 2021, the Company issued 348 shares
of its restricted common stock to consultants in exchange for services at a fair value of $999.
On September 15, 2021, the Company issued 793 shares
of its restricted common stock to consultants in exchange for services at a fair value of $2,500.
On October 25, 2021, the Company entered into
a securities purchase agreement with institutional investors resulting in the raise of $3,407,250 in gross proceeds to the Company.
Pursuant to the terms of the purchase agreement, the Company agreed to sell, in a registered direct offering, an aggregate of 850,000 shares
of the Company’s common stock, par value $0.001 per share, at a purchase price of $4.50 per Share.
On November 5, 2021, the Company issued 25,000 shares
of its restricted common stock to consultants in exchange for services at a fair value of $85,750.
On November 15, 2021, the Company issued 13,392 shares
of its restricted common stock to consultants in exchange for services at a fair value of $41,917.
On November 29, 2021, the Company issued 250,000 shares
of its restricted common stock to settle outstanding vendor liabilities of $576,783. In connection with this transaction the Company
also recorded a loss on settlement of vendor liabilities of $33,217.
On November 29, 2021, the Company issued 101,097 shares
of its restricted common stock to consultants in exchange for services at a fair value of $246,676.
On December 3, 2021, the Company issued 194 shares
of its restricted common stock to consultants in exchange for services at a fair value of $429.
On December 14, 2021, the Company issued 211 shares
of its restricted common stock to consultants in exchange for services at a fair value of $452.
During the year ended December 31, 2022, the Company
issued 307,342 shares of its restricted common stock to settle outstanding vendor liabilities of $138,125. In connection with this
transaction the Company also recorded a loss on settlement of vendor liabilities of $265,717.
On January 6, 2022, the Company issued 8,850 shares
of its restricted common stock to consultants in exchange for services at a fair value of $19,736.
On February 24, 2022, the Company issued 50,000 shares
of its restricted common stock to consultants in exchange for four months of services at a fair value of $69,000. These shares were
recorded as common stock issued for prepaid services and will be expensed over the life of the consulting contract to share based payments.
During the nine months ended September 30, 2022 the Company recorded $69,000 to share based payments.
On March 1, 2022, the Company entered into
securities purchase agreements with twenty-eight accredited investors whereby, at the closing, such investors purchased from the Company
an aggregate of 1,401,457 shares of the Company’s common stock and (ii) 1,401,457 warrants to purchase shares of common stock,
for an aggregate purchase price of $2,452,550. Such warrants are exercisable for a term of five-years from the date of issuance, at an
exercise price of $1.75 per share. The Company has recorded $40,000 to stock issuance costs, which are part of Additional Paid-in
Capital.
On March 7, 2022, the Company entered into
a securities purchase agreement (the “Purchase Agreement”) with thirteen accredited investors resulting in the raise of $2,659,750 in
gross proceeds to the Company. Pursuant to the terms of the Purchase Agreement, the Company agreed to sell in a registered direct offering
an aggregate of 1,519,857 shares of the Company’s common stock together with warrants to purchase an aggregate of 1,519,857 shares
of Common Stock at an exercise price of $1.75 per share. The warrants are immediately exercisable and will expire on March 9, 2027.
The Company has recorded $75,000 to stock issuance costs, which are part of Additional Paid-in Capital.
During the three months ended March
31, 2022, the Company issued 7,488 shares of its restricted common stock to consultants in exchange for services at a fair
value of $8,364.
On April 5, 2022 the Company issued 185,000 shares
of its restricted common stock to officers of the company in exchange for services at a fair value of $192,400.
On June 24, 2022, the Company issued 50,000 shares
of its restricted common stock to consultants in exchange for four months of services at a fair value of $37,200. These shares were
recorded as common stock issued for prepaid services and will be expensed over the life of the consulting contract to share based payments.
During the nine months ended September 30, 2022 the Company recorded $2,405 to share based payments.
During the three months ended June 30, 2022,
the Company issued 29,387 shares of its restricted common stock to consultants in exchange for services at a fair value of
$24,001.
On September 15, 2022, the Company entered
into a securities purchase agreement with five accredited investors resulting in the raise of $796,000 in gross proceeds to the Company.
Pursuant to the terms of the Purchase Agreement, the Company agreed to sell in a registered direct offering an aggregate of 4,000,000 shares
of the Company’s common stock together with warrants to purchase an aggregate of 4,000,000 shares of Common Stock at an exercise
price of $0.20 per share. The warrants are immediately exercisable and will expire on September 15, 2027. The Company has recorded
$75,000 to stock issuance costs, which are part of Additional Paid-in Capital.
During the three months ended September 30, 2022,
the Company issued 50,000 shares of its restricted common stock to consultants in exchange for prepaid services at a fair value
of $34,900.
During the three months ended September 30, 2022,
the Company issued 107,206 shares of its restricted common stock to consultants in exchange for services at a fair value of
$22,892.
During the three months ended December 31, 2022,
the Company issued 111,324 shares of its restricted common stock to consultants in exchange for services at a fair value of
$44,894.
During the year ended December 31, 2022, the
company repurchased 87,716 shares of common stock for $16,050.
Stock Options
The assumptions used for options granted during
the twelve months ended December 31, 2022 and 2021, are as follows:
| |
December 31, 2022 | |
Exercise price | |
$ | 1.10 – 1.90 | |
Expected dividends | |
| 0 | % |
Expected volatility | |
| 165.38% – 166.48 | % |
Risk free interest rate | |
| 2.69% – 2.95 | % |
Expected life of option | |
| 5 years | |
| |
December 31, 2021 | |
Exercise price | |
$ | 2.09 - 4.89 | |
Expected dividends | |
| 0 | % |
Expected volatility | |
| 169.78 – 242.98 | % |
Risk free interest rate | |
| 0.46 – 1.26 | % |
Expected life of option | |
| 5 - 7 years | |
The following is a summary of the Company’s
stock option activity:
| |
Options | | |
Weighted Average Exercise Price | | |
Weighted Average Remaining Contractual Life (in years) | |
Balance – January 1, 2021 – outstanding | |
| 541,021 | | |
| 12.75 | | |
| 3.27 | |
Granted | |
| 2,425,762 | | |
| 5.97 | | |
| 5.91 | |
Exercised | |
| - | | |
| - | | |
| - | |
Forfeited/Cancelled | |
| (64,164 | ) | |
| 13.06 | | |
| - | |
Balance – December 31, 2021 – outstanding | |
| 2,902,619 | | |
| 7.07 | | |
| 4.71 | |
Granted | |
| 1,940,000 | | |
| 1.38 | | |
| 5.00 | |
Exercised | |
| - | | |
| - | | |
| - | |
Forfeited/Cancelled | |
| (434,352 | ) | |
| 13.56 | | |
| - | |
Balance – December 31, 2022 – outstanding | |
| 4,408,267 | | |
| 4.05 | | |
| 4.29 | |
Balance – December 31, 2022 – exercisable | |
| 3,061,767 | | |
| 4.19 | | |
| 4.07 | |
Option Outstanding | | |
Option Exercisable | |
Exercise price | | |
Number Outstanding | | |
Weighted Average Remaining Contractual Life (in years) | | |
Weighted Average Exercise Price | | |
Number Exercisable | | |
Weighted Average Remaining Contractual Life (in years) | |
$ | 4.05 | | |
| 4,408,267 | | |
| 4.29 | | |
| 4.19 | | |
| 3,061,767 | | |
| 4.07 | |
Stock-based compensation for stock options has
been recorded in the consolidated statements of operations and totaled $7,616,195, for the year ended December 31, 2021.
Stock-based compensation for stock options has
been recorded in the consolidated statements of operations and totaled $3,757,514, for the year ended December 31, 2022.
As of December 31, 2022, there was $237,522 of
total unrecognized compensation expense related to unvested employee options granted under the Company’s share-based compensation
plans that is expected to be recognized over a weighted average period of approximately 0.14 years.
Warrants
The Company applied fair value accounting for
all share-based payments awards. The fair value of each warrant granted is estimated on the date of grant using the Black-Scholes option-pricing
model.
The assumptions used for warrants granted during
the year ended December 31, 2022 and 2021 are as follows:
|
|
December 31,
2022 |
|
Exercise price |
|
$ |
0.20 – 6.00 |
|
Expected dividends |
|
|
0 |
% |
Expected volatility |
|
|
164.34% - 175.30 |
% |
Risk free interest rate |
|
|
2.81% - 3.75 |
% |
Expected life of warrant |
|
|
5-5.5 years |
|
|
|
|
|
|
| |
December
31, 2021 | |
Exercise price | |
$ | 4.50 – 5.40 | |
Expected dividends | |
| 0 | % |
Expected volatility | |
| 232.10% - 237.14 | % |
Risk free interest rate | |
| 0.82% - 0.89 | % |
Expected life of warrant | |
| 5 – 5.5 years | |
Warrant Activities
The following is a summary of the Company’s
warrant activity:
| |
Warrant | | |
Weighted Average Exercise Price | |
Balance – January 1, 2022 – outstanding | |
| 6,130,948 | | |
| 4.96 | |
Granted | |
| 1,961,267 | | |
| 5.60 | |
Exercised | |
| (2,414,218 | ) | |
| 4.55 | |
Forfeited/Cancelled | |
| (19,167 | ) | |
| 24.00 | |
Balance – December 31, 2021 – outstanding | |
| 5,658,830 | | |
| 4.98 | |
Granted | |
| 22,460,182 | | |
| 2.07 | |
Exercised | |
| (9,624,067 | ) | |
| 5.18 | |
Forfeited/Cancelled | |
| (2,233,246 | ) | |
| 4.73 | |
Balance – December 31, 2022 – outstanding | |
| 16,261,699 | | |
| 2.18 | |
Balance – December 31, 2022 – exercisable | |
| 16,261,699 | | |
$ | 2.79 | |
Warrants Outstanding | | |
Warrants Exercisable | |
Exercise price | | |
Number Outstanding | | |
Weighted Average Remaining Contractual Life (in years) | | |
Weighted Average Exercise Price | | |
Number Exercisable | | |
Weighted Average Exercise Price | |
$ | 2.18 | | |
| 16,261,699 | | |
| 4.20 | | |
| 2.79 | | |
| 16,261,699 | | |
| 4.20 | |
During the Year ended December 31, 2021, the
Company issued 2,250,691 shares of common stock to a certain warrant holder upon the exercise of 2,414,218 warrants.
The Company received $9,487,223 in connection with the exercise of the warrant.
During the year ended December 31, 2021, a total
of 486,516 warrants were issued in connection with the Series E Convertible Preferred Stock raise.
During the year ended December 31, 2021, a total
of 1,137,575 warrants were issued with convertible notes. The warrants have a grant date fair value of $3,258,955 using
a Black-Scholes option-pricing model and the above assumptions.
During the year ended December 31, 2021, some
of the Company’s warrants had a down-round provision triggered that also resulted in an additional 127,801 warrants to
be issued. A deemed dividend of $410,750 was recorded to the Statements of Comprehensive Loss.
During the year ended December 31, 2021, the
Company issued 80,000 warrants in connection with the underwriting agreement.
Stock-based compensation for stock warrants of 129,375 has
been recorded in the Consolidated Statements of Comprehensive Loss and totaled $480,863, for the year ended December 31, 2021.
During the year ended December 31, 2022, the company
granted warrant holders 5,246,953 warrants to exercise existing warrants. A deemed dividend of $4,216,528 was recorded to the Statements
of Operations and Comprehensive Loss.
During the year ended December 31, 2022, a total
of 6,712,500 warrants were issued with convertible notes (See Note 7 above). The warrants have a grant date fair value of $6,172,614
using a Black-Scholes option-pricing model and the above assumptions and a relative fair value of $3,171,076.
Note 11 – Commitments and Contingencies
Litigation
Skube v. WHE Agency Inc., et al
A complaint against WHE, Creatd and
Jeremy Frommer filed December 22, 2022, was filed in the Supreme Court of the State of New York, New York County, by Jessica Skube,
making certain claims alleging conversion, trespass to chattel, unjust enrichment, breach of contract, fraud in the inducement,
seeking damages of $161,000 and punitive damages of $500,000. Skube filed an Order to Show Cause, which the Company opposed,
which is currently pending. The contingency is probable that a material loss of $161,000 has been incurred and is accrued in the
Company’s consolidated financial statements.
Lind Global v. Creatd, Inc.
A complaint against Creatd dated September
21, 2022, has been filed in the Supreme Court of the State of New York, New York County, by Lind Global Macro Fund LP and Lind
Global Fund II LP, making certain claims alleging breach of contract related to two Securities Purchase Agreements executed
on May 31, 2022, seeking damages in excess of $920,000. The Company filed a Motion to Dismiss, which is currently pending. Given
the premature nature of this case, it is still too early for the Company to make an assessment as to liability.
Inflation Reduction Act of 2022
On August 16, 2022, the Inflation Reduction Act of
2022 (“IRA”) was signed into law. The IRA includes a 15% Corporate Alternative Minimum Tax (“Corporate AMT”)
for tax years beginning after December 31, 2022. We do not expect the Corporate AMT to have a material impact on our consolidated financial
statements. Additionally, the IRA imposes a 1% excise tax on net repurchases of stock by certain publicly traded corporations. The excise
tax is imposed on the value of the net stock repurchased or treated as repurchased. The new law will apply to stock repurchases occurring
after December 31, 2022.
Lease Agreements
The Company currently does not own any properties.
Our corporate headquarters consists of a total of 8,000 square feet and is located at 419 Lafayette Street, 6th Floor, New York, NY, 10003.
The current lease term is 7 years commencing May 1, 2022. The total amount due under this lease is $3,502,033.
On April 19, 2022, the Company signed a 2-year
lease for approximately 2,252 square feet of office space at 1 Westmount Square, Westmount, Qc H3Z2P9. Commencement date
of the lease is July 1, 2022. The total amount due under this lease is $72,064. During the year ended December 31, 2022, it was decided
the company would not be using the office space and recorded an impairment of $63,472 on the right-of-use asset. As of December 31, 2022,
the company was in breach of this lease agreement and subsequently reached a settlement agreement to terminate the lease.
On July 28, 2022, the Company signed a 3-year
lease for approximately 1,364 square feet of office space at 1674 Meridian Ave., Miami Beach, FL, 33131. Commencement
date of the lease is July 28, 2022. The total amount due under this lease is $181,299. During the year ended December 31, 2022, it was
decided the company would not be using the office space and recorded an impairment of $101,623 on the right-of-use asset. As of December
31, 2022, the company is in breach of this lease agreement.
On September 9, 2021, the Company signed a 1-year
lease for approximately 3,200 square feet at 648 Broadway, Suite 200, New York, NY 10012. Monthly rent under the lease was $12,955 for
the leasing period. As of December 31, 2022, the company is in breach of this lease agreement.
The components of lease expense were as follows:
| |
Year Ended December 31,
2022 | |
Operating lease cost | |
$ | 398,498 | |
Short term lease cost | |
| 139,136 | |
Total net lease cost | |
$ | 537,634 | |
Supplemental cash flow and other information
related to leases was as follows:
| |
Year Ended December 31,
2022 | |
Cash paid for amounts included in the measurement of lease liabilities: | |
| |
Operating lease payments | |
| 206,944 | |
Weighted average remaining lease term (in years): | |
| 6.02 | |
Weighted average discount rate: | |
| 12.50 | % |
Total future minimum payments required under
the lease as of December 31, are as follows:
For the Twelve Months Ended December 31, | |
Operating Leases | |
2023 | |
$ | 583,728 | |
2024 | |
| 550,705 | |
2025 | |
| 517,231 | |
2026 | |
| 532,424 | |
2027 | |
| 548,073 | |
Thereafter | |
| 754,064 | |
Total lease payments | |
| 3,486,225 | |
Less: Amounts representing interest | |
| (1,081,698 | ) |
Total lease obligations | |
| 2,404,526 | |
Less: Current | |
| (326,908 | ) |
| |
$ | 2,077,618 | |
Rent expense for the year ended December 31, 2022
and 2021 was $590,100 and $216,845, respectively.
Market price risk of crypto (“digital”)
assets
The Company holds crypto and digital assets in
third-party wallets. Crypto asset price risk could adversely affect its operating results and will depend upon the market price of Bitcoin,
ETH, as well as other crypto assets. Crypto asset prices have fluctuated significantly from quarter to quarter. There is no assurance
that crypto asset prices will reflect historical trends. A decline in the market price of Bitcoin, ETH, and Other crypto assets could
have an adverse effect on our earnings, the carrying value of the crypto assets, and future cash flows. This may also affect the liquidity
and the ability to meet our ongoing obligations.
Appointment of New Directors
On February 17, 2022, the Board of Directors
(the “Board”) of the Company appointed Joanna Bloor, Brad Justus, and Lorraine Hendrickson to serve as members of the Board.
Ms. Bloor has been nominated to, and will serve as, chair of the Compensation Committee, and to be a member of the Audit Committee and
Nominating & Corporate Governance Committee. Mr. Justus has been nominated, and will serve as, chair of the Nominating & Corporate
Governance Committee, and to be a member of the Compensation Committee and Audit Committee. Ms. Hendrickson has been nominated to, and
will serve as, chair of the Audit Committee and to be a member of the Compensation and Nominating & Corporate Governance Committee.
Management Restructuring
On February 17, 2022, the Board of the Company
approved the restructuring of the Company’s senior management team to eliminate the Co-Chief Executive Officer role, appointing
Jeremy Frommer as Executive Chairman and Founder, and appointing Laurie Weisberg as Chief Executive Officer (the “Second Restructuring”).
Prior to the Second Restructuring, Mr. Frommer and Ms. Weisberg served as the Company’s co-Chief Executive Officers and Ms. Weisberg
served as the Company’s Chief Operating Officer. The Second Restructuring does not impact the role or functions of the Company’s
Chief Financial Officer, Chelsea Pullano, or the role or functions of the Company’s President and Chief Operating Officer, Justin
Maury.
Departure of Directors
On February 17, 2022, the Board received notice
that effective immediately, Mark Standish resigned as Chair of the Board, Chair of the Audit Committee and as a member of the Compensation
Committee and Nominating & Corporate Governance Committee; Leonard Schiller resigned as member of the Board, Chair of the Compensation
Committee and as a member of the Audit Committee and Nominating & Corporate Governance Committee; and LaBrena Martin resigned as a
member of the Board, Chair of the Nominating & Corporate Governance Committee and as a member of the Audit Committee and Compensation
Committee. Such resignations are not the result of any disagreement with the Company on any matter relating to the Company’s operations,
policies or practices.
On September 2, 2022, the Company entered into
an Executive Separation Agreement with Laurie Weisberg the Company’s Chief Executive Officer and member of the Board of Directors
setting forth the terms and conditions related to the Executive’s resignation for good reason as Chief Executive Officer, Director
and any other positions held with the Company or any subsidiary.
On September 21, 2022,
the Board received notice from Brad Justus of his resignation as a member of the Board, and from all committees of the Board on which
he served, with such resignation to become effective on September 30, 2022. Such resignation was not the result of any disagreement with
the Company on any matter relating to the Company’s operations, policies or practices.
On November 1, 2022,
the Board received notice from Lorraine Hendrickson of her resignation as a Director and from all committees of the Board on which she
served, effective as of such date. Ms. Hendrickson’s resignation as a member of the Board was not the result of any disagreement
with the Company on any matter relating to the Company’s operations, policies or practices.
On November 17, 2022,
the Board received notice from Joanna Bloor of her resignation as a Director and from all committees of the Board on which she served,
effective as of such date. Ms. Bloor’s resignation as a member of the Board was not the result of any disagreement with the Company
on any matter relating to the Company’s operations, policies or practices.
Appointment of
New Directors
On September 2, 2022,
the Board appointed Justin Maury, President and Chief Operating Officer, as Director to the Board
On November 2, 2022, the Board appointed Peter
Majar as Director to the Board. Mr. Majar has been nominated to, and will serve as, chair of the Audit Committee and the Compensation
Committee and to be a member of the Nominating & Corporate Governance Committee.
On November 16, 2022,
the Board appointed Erica Wagner as Director to the Board. Ms. Wagner has been nominated, and will serve as, chair of the Nominating
& Corporate Governance Committee, and to be a member of the Compensation Committee.
Nasdaq Notice of Delisting
On September 2, 2022, the Company received a
letter from the staff of The Nasdaq Capital Market notifying the Company that the Nasdaq Hearings Panel has determined to delist the
Company’s common stock from the Exchange, based on the Company’s failure to comply with the listing requirements of Nasdaq
Rule 5550(b)(1) as a result of the Company’s shareholder equity deficit for the period ended June 30, 2022, as demonstrated in
Company’s Quarterly Report on Form 10-Q filed on August 15, 2022, following the Company having not complied with the market value
of listed securities requirement in Nasdaq Rule 5550(b)(2) on March 1, 2022, while the Company was under a Panel Monitor, as had been
previously disclosed. Suspension of trading in the Company’s shares on the Exchange became effective at the opening of business
on September 7, 2022, at which time the Company’s common stock, under the symbol “CRTD,” and publicly-traded warrants,
under the symbol “CRTDW,” was quoted on the OTCPink marketplace operated by OTC Markets Group Inc.
Following passage of the proscribed 15-day time
period for appeal as stated in the Letter, on October 26, 2022, Nasdaq completed the delisting by filing a Form 25 Notification of Delisting
with the Securities and Exchange Commission.
The Company’s common stock, under the symbol
“CRTD,” is quoted on the OTCQB marketplace operated by OTC Markets Group Inc. effective as of September 26, 2022. Effective
April 4, 2023, our symbol changed to “VOCL.” The Company’s publicly-traded warrants, under the symbol “CRTDW,”
are quoted on the OTCPink marketplace operated by OTC Markets Group Inc.
Employment Agreements
On April 5, 2022, upon the recommendation of
the Compensation Committee of the Board, the Board approved employment agreements with, and equity issuances for, (i) Jeremy Frommer,
Executive Chairman, who will receive (a) an signing award of $80,000, (b) an annual salary of $420,000; (c) 121,000 options, to vest
immediately with a strike price of $1.75, and (d) 50,000 shares of the Company’s restricted common stock; (ii) Laurie Weisberg,
Chief Executive Officer, who will receive (a) an annual salary of $475,000; (b) 121,000 options, to vest immediately with a strike price
of $1.75, and (c) 50,000 shares of the Company’s restricted common stock; (iii) Justin Maury, Chief Operating Officer & President,
who will receive (a) an annual salary of $475,000 (b) 81,000 options, to vest immediately with a strike price of $1.75, and (c) 50,000
shares of the Company’s restricted common stock; and (iv) Chelsea Pullano, Chief Financial Officer, who will receive (a) an annual
salary of $250,000; (b) 37,000 options, to vest immediately with a strike price of $1.75, and (c) 35,000 shares of the Company’s
restricted common stock (collectively, the “Executive Employment Arrangements”).
Pursuant to the Executive Employment Arrangements,
the Company entered into executive employment agreements with each of the respective executives as of April 5, 2022 (the “Executive
Employment Agreements”). The Executive Employment Agreements contain customary terms, conditions and rights.
Executive Separation Agreement
On September 2, 2022, the Company entered into
an Executive Separation Agreement with Laurie Weisberg the Company’s Chief Executive Officer and member of the Board of Directors
setting forth the terms and conditions related to the Executive’s resignation for good reason as Chief Executive Officer, Director
and any other positions held with the Company or any subsidiary.
The Company will pay severance in the aggregate
amount of $475,000, payable as follows: (i) 1/24 will be paid on each of September 15, 2022, October 1, 2022 and November 1, 2022, respectively;
(ii) 1/8 will be paid on each of December 1, 2022, January 1, 2023 and February 1, 2023, respectively; (iii) 1/4 will be paid on April
1, 2023; and (iv) the balance will be paid on May 1, 2023. The Company has executed and delivered a Confession of Judgment concerning
the severance amount, which is being held in escrow pending satisfaction of payment.
Additionally, all unvested and/or outstanding
stock options held by Ms. Weisberg as of the date of the separation agreement that are not subject to metric based vesting shall automatically
and fully vest. All unvested and/or outstanding stock options held by Ms. Weisberg as of the date of the separation agreement that are
subject to metric based vesting shall vest in accordance with their respective original terms.
Note 12 – Acquisitions
Plant Camp LLC
On June 1, 2021, the Company, entered into a
Membership Interest Purchase Agreement (the “MIPA”) with Angela Hein (“Hein”) and Heidi Brown (“Brown”,
and together with Hein, the “Sellers”), pursuant to which the Purchaser acquired 490,863 common units (the
“Membership Interests”) of Plant Camp LLC, a Delaware limited liability company (“Plant Camp”) from the Sellers,
resulting in the Purchaser owning 33% of the issued and outstanding equity of Plant Camp. The Membership Interests were purchased
for $175,000.
On June 4, 2021, the Company, entered into a
MIPA with Sellers, pursuant to which the Purchaser acquired 841,005 common units of Plant Camp from the Sellers, resulting
in the Purchaser owning a total of 89% of the issued and outstanding equity of Plant Camp. The additional Membership Interests were
purchased for $300,000. The acquisition was accounted for as a step acquisition however there was no change in value of the Company’s
existing equity interest. The Company utilized the fair value of the consideration to determine the fair value of the existing equity
interest based on the total merger consideration offered.
The following sets forth the components of the
purchase price:
Purchase price: | |
| |
Cash paid to seller | |
$ | 300,000 | |
Fair value of equity investment purchased on June 1, 2021 | |
| 175,000 | |
Total purchase price | |
| 475,000 | |
| |
| | |
Assets acquired: | |
| | |
Cash | |
| 5,232 | |
Accounts Receivable | |
| 7,645 | |
Inventory | |
| 19,970 | |
Total assets acquired | |
| 32,847 | |
| |
| | |
Liabilities assumed: | |
| | |
Accounts payable and accrued expenses | |
| 5,309 | |
Deferred Revenue | |
| 671 | |
Total liabilities assumed | |
| 5,980 | |
| |
| | |
Net assets acquired | |
| 26,867 | |
| |
| | |
Non-controlling interest in consolidated subsidiary | |
| 56,865 | |
| |
| | |
Excess purchase price | |
$ | 504,998 | |
The following
table provides a summary of the final allocation of the excess purchase price.
Goodwill | |
$ | 7,198 | |
Trade Names & Trademarks | |
| 100,000 | |
Know-How and Intellectual Property | |
| 316,500 | |
Website | |
| 51,300 | |
Customer Relationships | |
| 30,000 | |
| |
| | |
Excess purchase price | |
$ | 504,998 | |
The goodwill
represents the assembled workforce, acquired capabilities, and future economic benefits resulting from the acquisition.
WHE Agency, Inc.
On July
20, 2021, the Company entered into a Stock Purchase Agreement to purchase 44% ownership and 55% of voting power of the issued
and outstanding shares of WHE Agency, Inc., (“WHE”). The aggregate closing consideration was $1,038,271, which consists of
a combination of $144,750 in cash and $893,521 in the form of 224,503 shares of the Company’s restricted common
stock at a price of $3.98 per share. Based on the purchase price of $1,038,271 for 44% ownership, the fair value of the
non-controlling interest was estimated to be $1,190,000 based on the consideration from the Company.
WHE is a
talent management and public relations agency dedicated to the representation and management of family- and lifestyle-focused influencers
and digital creators.
The following
sets forth the components of the purchase price:
Purchase price: | |
| |
Cash paid to seller | |
$ | 144,750 | |
Shares granted to seller | |
| 893,521 | |
Total purchase price | |
| 1,038,271 | |
| |
| | |
Assets acquired: | |
| | |
Cash | |
| 26,575 | |
Accounts Receivable | |
| 446,272 | |
Total assets acquired | |
| 472,847 | |
| |
| | |
Liabilities assumed: | |
| | |
Accounts payable and accrued expenses | |
| 353,017 | |
Total liabilities assumed | |
| 353,017 | |
| |
| | |
Net assets acquired | |
| 119,830 | |
| |
| | |
Non-controlling interest in consolidated subsidiary | |
| 1,190,000 | |
| |
| | |
Excess purchase price | |
$ | 2,108,442 | |
The following
table provides a summary of the final allocation of the excess purchase price.
Goodwill | |
$ | 1,349,697 | |
Trade Names & Trademarks | |
| 85,945 | |
Non-Compete Agreements | |
| 45,190 | |
Influencers / Customers | |
| 627,610 | |
Excess purchase price | |
$ | 2,108,442 | |
The goodwill
represents the assembled workforce, acquired capabilities, and future economic benefits resulting from the acquisition.
Dune Inc.
Prior to
October 3, 2021, the Company invested $732,297 into Dune See note 6 & 7. Using step acquisition accounting, the Company decreased
the value of its existing equity interest to its fair value based on its purchase price on October 3, 2021, resulting in the recognition
of an impairment in investment of $424,632, which was included in within our consolidated statements of operations. The Company utilized
the fair value of the consideration to determine the fair value of the existing equity interest based on the total merger consideration
offered and the Company’s stock price at acquisition.
On October
3, 2021, we, through Creatd Partners, LLC (“Buyer”), entered into a Stock Purchase Agreement (the “Dune Agreement”)
with Standard Holdings, Inc. (“SHI”) and Mark De Luca (“De Luca”) (SHI and De Luca, collectively the “Dune
Sellers”), and Stephanie Roy Dufault, whereby Buyer purchased a majority stake in Dune, Inc., a Delaware corporation (“Dune”).
Pursuant to the Dune Agreement, which closed on October 4, 2021, Buyer acquired a total of 3,905,634 shares of the common stock
of Dune (the “Purchased Shares”). The Company issued 163,344 restricted shares of the Company’s common stock
to the Dune Sellers.
In addition,
pursuant to the Dune Agreement, $50,000 worth of the Company’s common stock issuable to the Dune Sellers on a pro rata basis,
priced in accordance with the terms and conditions set forth in the Dune Agreement (the “Indemnification Escrow Amount”),
shall be held in escrow and reserved in each Dune Seller’s name by the Company’s transfer agent until such time as release
is authorized under the Agreement.
The following sets forth the
components of the purchase price:
Purchase price: | |
| |
Shares granted to seller | |
$ | 424,698 | |
Fair value of equity investment purchased before October 4, 2021 | |
| 307,665 | |
Total purchase price | |
| 732,363 | |
| |
| | |
Assets acquired: | |
| | |
Cash | |
| 186,995 | |
Inventory | |
| 47,250 | |
Total assets acquired | |
| 234,246 | |
| |
| | |
Liabilities assumed: | |
| | |
Accounts payable | |
| 40,000 | |
Total liabilities assumed | |
| 40,000 | |
| |
| | |
Net assets acquired | |
| 194,246 | |
| |
| | |
Non-controlling interest in consolidated subsidiary | |
| 720,581 | |
| |
| | |
Excess purchase price | |
$ | 1,258,698 | |
Due to the
limited amount of time since the acquisition date, the assets and liabilities of Dune Inc. were recorded based primarily on their acquisition
date carrying values. Management believes the estimated fair value of these accounts on the acquisition date approximates their carrying
value as reflected in the table above due to the short-term nature of these instruments. The remaining assets and liabilities primarily
consisted of goodwill, customer relationships, know how, and tradenames. We will adjust the remaining assets and liabilities to fair value
as valuations are completed and we obtain information necessary to complete the analyses, but no later than one year from the acquisition
data.
The following
table provides a summary of the final allocation of the excess purchase price.
Goodwill | |
$ | 64,230 | |
Trade Names & Trademarks | |
| 208,304 | |
Know-How and Intellectual Property | |
| 858,300 | |
Website | |
| 127,864 | |
Excess purchase price | |
$ | 1,258,698 | |
The goodwill
represents the assembled workforce, acquired capabilities, and future economic benefits resulting from the acquisition.
Denver Bodega, LLC d/b/a Basis
On March 7, 2022, the Company entered into a Membership
Interest Purchase (the “Agreement”) with Henry Springer and Kyle Nowak (collectively the “Sellers”), whereby
the Company purchased a majority stake in Denver Bodega, LLC, a Colorado limited liability company whose product is Basis, a direct-to-consumer
functional beverage brand that makes high-electrolyte mixes meant to aid hydration. Pursuant to the Agreement, Creatd acquired all of
the issued and outstanding membership interests of Denver Bodega, LLC for consideration of one dollar ($1.00), as well as the Company’s
payoff, assumption, or satisfaction of certain debts and liabilities.
The following sets forth the components of the
purchase price:
Purchase price: | |
| |
Cash paid to seller | |
$ | 1 | |
Total purchase price | |
| 1 | |
| |
| | |
Assets acquired: | |
| | |
Cash | |
| 44,977 | |
Accounts Receivable | |
| 2,676 | |
Inventory | |
| 194,365 | |
Total assets acquired | |
| 242,018 | |
| |
| | |
Liabilities assumed: | |
| | |
Accounts payable and accrued expenses | |
| 127,116 | |
Notes payable | |
| 293,888 | |
Total liabilities assumed | |
| 421,004 | |
| |
| | |
Net liabilities acquired | |
| (178,986 | ) |
| |
| | |
Excess purchase price | |
$ | 178,987 | |
The following table provides a summary of the
preliminary allocation of the excess purchase price.
Goodwill | |
$ | 12,691 | |
Trade Names & Trademarks | |
| 19,970 | |
Know-How and Intellectual Property | |
| 107,633 | |
Customer Relationships | |
| 38,693 | |
Excess purchase price | |
$ | 178,987 | |
The goodwill represents the assembled workforce,
acquired capabilities, and future economic benefits resulting from the acquisition.
Orbit Media, LLC
On August 1, 2022 the Company entered into
a Membership Interest Purchase (the “Agreement”) with Zachary Shenkman, Wuseok Jung, Wesley Petry, Nicholas Scibilia, Gary
Rettig, Brandon Fallin (collectively the “Sellers”), whereby the Company purchased a majority stake in Orbit Media LLC, a
New York limited liability company whose product is an app-based stock trading platform designed to empower a new generation of investors,
providing users with a like-minded community as well as access to tools, content, and other resources to learn, train, and excel in the
financial markets. Pursuant to the Agreement, Creatd acquired fifty one percent (51%) of the issued and outstanding membership interests
of Orbit Media LLC for consideration of forty-four thousand dollars ($44,000) in cash and 57,576 shares of the Company’s Common
Stock. This transaction was considered to be an acquisition of in-process research and development with no alternative future use. Orbit
Media, LLC is part of the Company’s consolidated subsidiaries as of December 31, 2022.
Brave Foods, LLC
On September 13, 2022, the Company acquired 100%
of the membership interests of Brave Foods, LLC, a Maine limited liability company for $150,000. Brave is a plant-based food company that
provides convenient and healthy breakfast food products.
The following sets forth the components of the
purchase price:
Purchase price: | |
| |
Cash paid to seller | |
$ | 150,000 | |
Total purchase price | |
| 150,000 | |
| |
| | |
Assets acquired: | |
| | |
Cash | |
| 73,344 | |
Inventory | |
| 46,375 | |
Total assets acquired | |
| 119,719 | |
| |
| | |
Liabilities assumed: | |
| | |
Accounts payable and accrued expenses | |
| 1,316 | |
Notes payable | |
| 75,000 | |
Total liabilities assumed | |
| 76,316 | |
| |
| | |
Net assets acquired | |
| 43,403 | |
Excess purchase price | |
$ | 106,596 | |
The excess purchase price amounts are provisional and may be adjusted
during the one-year measurement period as required by U.S. GAAP. It is likely that all intangible assets will be reallocated during
the measurement period. The following table provides a summary of the allocation of the excess purchase price.
Goodwill | |
$ | 46,460 | |
Trade Names & Trademarks | |
| 16,705 | |
Know-How and Intellectual Property | |
| 16,704 | |
Website | |
| 16,704 | |
Customer Relationships | |
| 10,023 | |
| |
| | |
Excess purchase price | |
$ | 106,596 | |
The goodwill represents the assembled workforce,
acquired capabilities, and future economic benefits resulting from the acquisition.
The following presents the unaudited pro-forma
combined results of operations of the Company with Plant Camp, WHE, Dune, Denver Bodega, and Brave as if the entities were combined on
January 1, 2021.
| |
Year Ended | |
| |
2021 | |
Revenues | |
$ | 6,492,696 | |
Net loss attributable to common shareholders | |
$ | (44,422,150 | ) |
Net loss per share | |
$ | (3.43 | ) |
Weighted average number of shares outstanding | |
| 12,934,549 | |
| |
Year Ended | |
| |
2022 | |
Revenues | |
$ | 5,482,827 | |
Net loss attributable to common shareholders | |
$ | (36,638,249 | ) |
Net loss per share | |
$ | (1.66 | ) |
Weighted average number of shares outstanding | |
| 22,092,836 | |
Note 13 – Segment Information
We operate in three reportable segments:
Creatd Labs, Creatd Ventures, and Creatd Partners. Our segments were determined based on the economic characteristics of our products
and services, our internal organizational structure, the manner in which our operations are managed and the criteria used by our Chief
Operating Decision Maker (CODM) to evaluate performance, which is generally the segment’s operating losses.
Operations of: |
|
Products and services provided: |
Creatd Labs |
|
Creatd Labs is the segment focused on development initiatives. Creatd Labs houses the Company’s proprietary technology, including its flagship platform, Vocal, as well as oversees the Company’s content creation framework, and management of its digital communities. Creatd Labs derives revenues from Vocal creator subscriptions, platform processing fees and technology licensing fees.
|
Creatd Ventures |
|
Creatd Ventures builds, develops, and scales e-commerce brands. This segment generates revenues through product sales of its two majority-owned direct-to-consumer brands, Camp and Dune Glow Remedy.
|
Creatd Partners |
|
Creatd Partners fosters relationships between brands and creators through its suite of agency services, including content marketing (Vocal for Brands), performance marketing (Seller’s Choice), and influencer marketing (WHE Agency). Creatd Partners derives revenues in the form of brand fees and talent management commissions. |
The following tables present certain financial
information related to our reportable segments and Corporate:
| |
As of December 31, 2022 | |
| |
Creatd Labs | | |
Creatd Ventures | | |
Creatd Partners | | |
Corporate | | |
Total | |
| |
| | |
| | |
| | |
| | |
| |
Accounts receivable, net | |
$ | - | | |
$ | 11,217 | | |
$ | 228,206 | | |
$ | - | | |
$ | 239,423 | |
Prepaid expenses and other current assets | |
| 23,712 | | |
| 40,681 | | |
| - | | |
| 64,154 | | |
| 128,547 | |
Deposits and other assets | |
| 629,955 | | |
| 2,600 | | |
| - | | |
| 164,676 | | |
| 797,231 | |
Intangible assets | |
| - | | |
| 207,301 | | |
| - | | |
| 22,783 | | |
| 230,084 | |
Goodwill | |
| - | | |
| 46,460 | | |
| - | | |
| - | | |
| 46,460 | |
Inventory | |
| 30,125 | | |
| 374,845 | | |
| - | | |
| - | | |
| 404,970 | |
All other assets | |
| - | | |
| - | | |
| - | | |
| 2,973,034 | | |
| 2,973,034 | |
Total Assets | |
$ | 683,792 | | |
$ | 683,104 | | |
$ | 228,206 | | |
$ | 3,224,647 | | |
$ | 4,819,749 | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Accounts payable and accrued liabilities | |
$ | 8,495 | | |
$ | 1,635,298 | | |
$ | 509,931 | | |
$ | 5,411,996 | | |
$ | 7,565,720 | |
Note payable, net of debt discount and issuance costs | |
| 130,615 | | |
| 184,160 | | |
| - | | |
| 1,368,919 | | |
| 1,683,694 | |
Deferred revenue | |
| 275,017 | | |
| - | | |
| 24,392 | | |
| - | | |
| 299,409 | |
All other Liabilities | |
| - | | |
| - | | |
| - | | |
| 7,774,125 | | |
| 7,774,125 | |
Total Liabilities | |
$ | 414,217 | | |
$ | 1,819,458 | | |
$ | 534,323 | | |
$ | 14,555,040 | | |
$ | 17,322,948 | |
| |
As of December 31, 2021 | |
| |
Creatd Labs | | |
Creatd Ventures | | |
Creatd Partners | | |
Corporate | | |
Total | |
| |
| | |
| | |
| | |
| | |
| |
Accounts receivable, net | |
$ | - | | |
$ | 2,884 | | |
$ | 334,556 | | |
$ | - | | |
$ | 337,440 | |
Prepaid expenses and other current assets | |
| 48,495 | | |
| - | | |
| - | | |
| 188,170 | | |
| 236,665 | |
Deposits and other assets | |
| 626,529 | | |
| - | | |
| - | | |
| 92,422 | | |
| 718,951 | |
Intangible assets | |
| - | | |
| 1,637,924 | | |
| 783,676 | | |
| 11,241 | | |
| 2,432,841 | |
Goodwill | |
| - | | |
| 25,139 | | |
| 1,349,696 | | |
| - | | |
| 1,374,835 | |
Inventory | |
| - | | |
| 106,403 | | |
| - | | |
| - | | |
| 106,403 | |
All other assets | |
| - | | |
| - | | |
| - | | |
| 3,966,124 | | |
| 3,966,124 | |
Total Assets | |
$ | 675,024 | | |
$ | 1,772,350 | | |
$ | 2,467,928 | | |
$ | 4,257,957 | | |
$ | 9,173,259 | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Accounts payable and accrued liabilities | |
$ | 9,693 | | |
$ | 766,253 | | |
$ | 6,232 | | |
$ | 2,948,362 | | |
$ | 3,730,540 | |
Note payable, net of debt discount and issuance costs | |
| 313,979 | | |
| - | | |
| - | | |
| 1,028,685 | | |
| 1,342,664 | |
Deferred revenue | |
| 161,112 | | |
| 13,477 | | |
| 59,570 | | |
| - | | |
| 234,159 | |
All other Liabilities | |
| - | | |
| - | | |
| - | | |
| 177,644 | | |
| 177,644 | |
Total Liabilities | |
$ | 484,784 | | |
$ | 779,730 | | |
$ | 65,802 | | |
$ | 4,154,691 | | |
$ | 5,485,007 | |
| |
For the year December 30, 2022 | |
| |
Creatd
Labs | | |
Creatd Ventures | | |
Creatd Partners | | |
Corporate | | |
Total | |
| |
| | |
| | |
| | |
| | |
| |
Net revenue | |
$ | 1,616,278 | | |
$ | 1,456,593 | | |
$ | 1,723,603 | | |
$ | - | | |
$ | 4,796,474 | |
Cost of revenue | |
| 2,000,970 | | |
| 2,807,285 | | |
| 1,300,951 | | |
| - | | |
| 6,109,206 | |
Gross margin (loss) | |
| (384,692 | ) | |
| (1,350,692 | ) | |
| 422,652 | | |
| - | | |
| (1,312,732 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Compensation | |
| 1,794,003 | | |
| 826,185 | | |
| 931,158 | | |
| 1,127,044 | | |
| 4,678,390 | |
Research and development | |
| 606,211 | | |
| - | | |
| 345,203 | | |
| - | | |
| 951,414 | |
Marketing | |
| 2,722,579 | | |
| 1,675,083 | | |
| 302,509 | | |
| - | | |
| 4,700,171 | |
Stock based compensation | |
| 864,507 | | |
| 781,928 | | |
| 887,627 | | |
| 1,649,782 | | |
| 4,183,844 | |
General and administrative not including depreciation, amortization, or Impairment | |
| 246,540 | | |
| 592,210 | | |
| 509,757 | | |
| 7,675,921 | | |
| 9,024,428 | |
Depreciation and amortization | |
| - | | |
| 143,360 | | |
| 132,683 | | |
| 316,096 | | |
| 592,139 | |
Impairment of intangibles | |
| 213,141 | | |
| 365,732 | | |
| - | | |
| 3,009,121 | | |
| 3,587,994 | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Total operating expenses | |
$ | 4,439,837 | | |
$ | 3,558,313 | | |
$ | 2,177,779 | | |
$ | 12,650,920 | | |
$ | 27,718,380 | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Interest expense | |
| (33,938 | ) | |
| 298 | | |
| - | | |
| (787,411 | ) | |
| (821,051 | ) |
All other expenses | |
| - | | |
| - | | |
| - | | |
| (5,824,152 | ) | |
| (5,824,152 | ) |
Other expenses, net | |
| (33,938 | ) | |
| 298 | | |
| - | | |
| (6,611,563 | ) | |
| (6,645,203 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Loss before income tax provision | |
$ | (4,858,467 | ) | |
$ | (4,908,707 | ) | |
$ | (1,755,127 | ) | |
$ | (19,262,483 | ) | |
$ | (35,676,315 | ) |
| |
For the year ended December 31, 2021 | |
| |
Creatd Labs | | |
Creatd Ventures | | |
Creatd Partners | | |
Corporate | | |
Total | |
| |
| | |
| | |
| | |
| | |
| |
Net revenue | |
$ | 1,926,374 | | |
$ | 90,194 | | |
$ | 2,283,149 | | |
$ | - | | |
$ | 4,299,717 | |
Cost of revenue | |
| 3,186,240 | | |
| 148,989 | | |
| 1,964,808 | | |
| - | | |
| 5,300,037 | |
Gross margin | |
| (1,259,866 | ) | |
| (58,940 | ) | |
| 318,341 | | |
| - | | |
| (1,000,320 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Research and development | |
| 758,293 | | |
| 131 | | |
| 225,104 | | |
| - | | |
| 983,528 | |
Marketing | |
| 8,182,935 | | |
| - | | |
| 962,698 | | |
| 481,349 | | |
| 9,626,982 | |
Stock based compensation | |
| 1,727,021 | | |
| 1,560,546 | | |
| 1,884,986 | | |
| 4,488,615 | | |
| 9,661,168 | |
Impairment of goodwill | |
| - | | |
| - | | |
| 1,035,795 | | |
| - | | |
| 1,035,795 | |
General and administrative not including depreciation, amortization, or Impairment | |
| 3,918,130 | | |
| 1,665,783 | | |
| 1,600,212 | | |
| 2,791,236 | | |
| 9,975,360 | |
Depreciation and amortization | |
| - | | |
| 100,633 | | |
| 252,730 | | |
| 44,076 | | |
| 397,440 | |
Impairment of intangibles | |
| - | | |
| - | | |
| 688,127 | | |
| - | | |
| 688,127 | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Total operating expenses | |
$ | 14,586,379 | | |
$ | 3,327,093 | | |
$ | 6,649,652 | | |
$ | 11,803,003 | | |
$ | 32,368,400 | |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Interest expense | |
| (12,706 | ) | |
| - | | |
| - | | |
| (359,400 | ) | |
| (372,106 | ) |
All other expenses | |
| - | | |
| - | | |
| - | | |
| (3,638,327 | ) | |
| (3,638,327 | ) |
Other expenses, net | |
| (12,706 | ) | |
| | | |
| | | |
| (3,997,727 | ) | |
| (4,010,433 | ) |
| |
| | | |
| | | |
| | | |
| | | |
| | |
Loss before income tax provision and equity in net loss from unconsolidated investments | |
$ | (15,858,951 | ) | |
$ | (3,385,888 | ) | |
$ | (6,331,311 | ) | |
$ | (11,803,003 | ) | |
$ | (37,379,153 | ) |
Note 14 –Income Taxes
Components of deferred tax assets
are as follows:
| |
December 31, 2022 | | |
December 31, 2021 | |
Net deferred tax assets – Non-current: | |
| | |
| |
Depreciation | |
$ | (24,850 | ) | |
$ | (70,194 | ) |
Amortization | |
| (876,459 | ) | |
| 95,115 | |
Stock based compensation | |
| 5,545,450 | | |
| 4,369,372 | |
Expected income tax benefit from NOL carry-forwards | |
| 20,744,537 | | |
| 15,073,606 | |
Less valuation allowance | |
| (25,388,679 | ) | |
| (19,467,900 | ) |
Deferred tax assets, net of valuation allowance | |
$ | - | | |
$ | - | |
Income Tax Provision in
the Consolidated Statements of Operations
A reconciliation of the federal
statutory income tax rate and the effective income tax rate as a percentage of income before income taxes is as follows:
| |
For the Year Ended December 31, 2021 | | |
For the Year Ended December 31, 2021 | |
| |
| | |
| |
Federal statutory income tax rate | |
| 21.0 | % | |
| 21.0 | % |
State tax rate, net of federal benefit | |
| 7.1 | % | |
| 7.1 | % |
| |
| | | |
| | |
Change in valuation allowance on net operating loss carry-forwards | |
| (28.1 | )% | |
| (28.1 | )% |
| |
| | | |
| | |
Effective income tax rate | |
| 0.0 | % | |
| 0.0 | % |
Based on
the available objective evidence, management believes it is more likely than not that the net deferred tax assets of the Company will
not be fully realizable for the years ended December 31, 2022 and 2021. Accordingly, management had applied a full valuation allowance
against net deferred tax assets as of December 31, 2022 and 2021.
As of December
31, 2022, the Company had approximately $74 million of federal net operating loss carryforwards available to reduce future taxable income
which will begin to expire in 2035 for both federal and state purposes.
On December
22, 2017, the Tax Cuts and Jobs Act of 2017 (the “Act”) was signed into law making significant changes to the Internal Revenue
Code of 1986, as amended (the “Code”). The Act reduces the federal corporate income tax rate from 35% to 21% effective
for tax years beginning after December 31, 2017. ASC 470 requires the Company to remeasure the existing net deferred tax asset in the
period of enactment. The Act also provides for immediate expensing of 100% or the costs of qualified property that is incurred and
placed in service during the period from September 27, 2017, to December 31, 2022. Beginning January 1, 2023, the immediate expensing
provision is phased down by 20% per year until it is completely phased out as of January 1, 2027. Additionally, effective January
1, 2018, the Act imposes possible limitations on the deductibility of interest expense. As a result of the provisions of the Act, the
Company’s deduction for interest expense could be limited in future years. The effects of other provisions of the Act are not expected
to have a material impact on the Company’s financial statements.
On December
22, 2017, the SEC staff issued Staff Accounting Bulletin No. 118 (“SAB 118”) to provide guidance on accounting for the tax
effects of the Act. SAB 118 provides a measurement period that begins in the reporting period that includes the Act’s enactment
date and ends when an entity has obtained, prepared and analyzed the information that was needed in order to complete the accounting requirements
under ASC 720. However, in no circumstance should the measurement period extend beyond one year from the enactment date. In accordance
with SAB 118, a company must reflect in its financial statements the income tax effects of those aspects of the Act for which the accounting
under ASC 740 is complete. SAB 118 provides that to the extent that a company’s accounting for certain income tax effects of the
Tax Act is incomplete, but it is able to determine a reasonable estimate, it must record a provisional estimate in the financial statements.
The Company
does not reflect a deferred tax asset in its financial statements but includes that calculation and valuation in its footnotes. We are
still analyzing the impact of certain provisions of the Act and refining our calculations. The Company will disclose any change in the
estimates as it refines the accounting for the impact of the Act.
Federal
and state tax laws impose limitations on the utilization of net operating losses and credit carryforwards in the event of an ownership
change for tax purposes, as defined in Section 382 of the Internal Revenue Code. Accordingly, the Company’s ability to utilize these
carryforwards may be limited as a result of an ownership change which may have already happened or may happen in the future. Such an ownership
change could result in a limitation in the use of the net operating losses in future years and possibly a reduction of the net operating
losses available.
Note 15 – Subsequent Events
Increase in Authorized Shares
On January 18, 2023, upon approval from our board
of directors and stockholders, we filed Second Amended and Restated Articles of Incorporation with the Secretary of State of the State
of Nevada for the purpose of increasing our authorized shares of Common Stock to 1,500,000,000.
Note Conversions
Subsequent to December 31, 2022, $1,417,782 in
principal of three convertible notes converted into 6,946,851 shares of common stock.
Note Repayments and Warrant Cancellations
Subsequent to December 31, 2022, the Company repaid $1,500,000 in convertible
notes, resulting in the cancellation of 1,216,008 warrants, per the Restructuring Agreements entered into on September 15, 2022.
Securities Purchase Agreements
Subsequent to December 31, 2022, the Company entered into a Securities
Purchase Agreement with an investor to purchase 1,562,500 shares of common stock for gross proceeds of $750,000.
Convertible Notes
Subsequent to December 31, 2022, the Company entered
into 3 convertible promissory notes with 3 investors for proceeds of $2,364,250.
Minority Investment in OG Collection, Inc.
Subsequent to December 31, 2022, an investor entered into a Subscription
Agreement whereby it purchased from OG Collection, Inc., a subsidiary of the Company (“OG”), 50,000 shares of common stock
of OG for a purchase price of $250,000, and, in connection therewith OG, the Company and the Investor entered into a Shareholder Agreement.
Additional Purchase of Orbit Media, LLC
Subsequent to December 31, 2022, the Company acquired
an additional 5% of the membership interests of Orbit Media, LLC., bringing our total membership interests to 56%. Orbit Media LLC., has
been consolidated due to the Company’s ownership of 85% voting control, and the results of operations have been included since the
date of acquisition in the Statements of Operations.
February 2023 Warrant Exchange
On February 10, 2023 the Company entered into
a letter agreement (the “Letter Agreement”), between Creatd and the respective holders of an aggregate of 2,161,415 warrants
(the “Warrants”) to issue to the holders, for each Warrant held by such Selling Stockholder, one new warrant to purchase one
share of the Company’s common stock in exchange for the immediate exercise of the Warrants. The new warrants are exercisable immediately,
for a term of 60 months, at a price of $0.77, subject to customary adjustment provisions.
March 2023 Warrant Exchange
On March 6, 2023 the Company entered a letter
agreement (the “Letter Agreement”), between Creatd, Inc. and the respective holders of an aggregate of 1,607,050 warrants
(the “Warrants”) to issue to the holders, for each Warrant held by such Selling Stockholder, one new warrant to purchase one
share of the Company’s common stock in exchange for the immediate exercise of the Warrants. The new warrants are exercisable immediately,
for a term of 60 months, at a price of $0.77, subject to customary adjustment provisions.
Additional Purchase of Dune, Inc.
Subsequent
to December 31, 2022, the Company acquired an additional 23% equity interest in Dune, Inc. bringing our total ownership to 85% .
Dune, Inc., has been consolidated due to the Company’s ownership of over 50% voting control, and the results of operations have
been included since the date of acquisition in the Statements of Operations.
Additional Purchase of WHE Agency, Inc.
Subsequent to December 31, 2022, the Company acquired
an additional 51% of the equity interest in WHE Agency, Inc. bringing our total ownership to 95%. WHE Agency, Inc., has been consolidated
due to the Company’s ownership of over 50% voting control, and the results of operations have been included since the date of acquisition
in the Statements of Operations.
Consultant Shares
Subsequent to December 31, 2022, the Company issued 3,142,780 shares
of Common Stock to consultants.
Employee & Officer Equity Awards
Subsequent to December 31, 2022, in recognition of certain employees
having accepted reduced salaries beginning August 22, 2023, the Company issued equity awards totaling 7,512,918 shares to non-officer
employees and 18,250,319 to officers of the Company. The fair value of these issuances is $16,134,193 and the Company will be paying approximately
$3,477,062 in payroll taxes on behalf of employees receiving these awards.
Equity Line of Credit
Subsequent to December 31, 2022, the Company drew down from its outstanding
Equity Line of Credit for total proceeds of $300,000.
21,133,750 Shares of Common Stock
PROSPECTUS
June 13, 2023